Amedeo Smart

Free Medical Literature Service


 

Amedeo

Neonatology

  Free Subscription

Articles published in
Pediatr Pulmonol
    March 2024
  1. MUEHLBACHER T, Boos V, Geiger LB, Ruegger CM, et al
    Analgosedation for less-invasive surfactant administration: Variations in practice.
    Pediatr Pulmonol. 2024;59:750-757.
    >> Share

  2. ALIYEV F, Kayki G, Annakkaya Kocyigit T, Iyigun I, et al
    Lung ultrasound scores within the first 3 days of life to predict respiratory outcomes.
    Pediatr Pulmonol. 2024;59:662-668.
    >> Share

  3. DRESS C, Hente E, Hossain MM, Hardie W, et al
    Body composition in children with cystic fibrosis treated with CFTR modulators versus modulator naive individuals.
    Pediatr Pulmonol. 2024;59:805-808.
    >> Share

  4. JAMES A, Li G, List R, Lonabaugh K, et al
    Analysis of iron status after initiation of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:669-678.
    >> Share

  5. MOLITOR SJ, Fidler AL, Sinisterra M, Everhart RS, et al
    Associations between symptoms of ADHD/ODD and health outcomes in youth with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:809-812.
    >> Share

  6. GRUBE PM, Autry EB, Kormelink LN, Young DC, et al
    A decade of change: The evolution of pharmacy services at U.S. cystic fibrosis centers.
    Pediatr Pulmonol. 2024;59:652-661.
    >> Share

  7. WOZNIAK PS, Makhoul L, Botros MM
    Bronchopulmonary dysplasia in adults: Exploring pathogenesis and phenotype.
    Pediatr Pulmonol. 2024;59:540-551.
    >> Share

  8. ABBINANTI A, Witt DM, Saunders J, Jones AE, et al
    Venous thromboembolism management in people with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:584-591.
    >> Share

  9. BOUTELEUX B, Beaufils F, Fayon M, Bui S, et al
    Home-spirometry exacerbation profiles in children with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:552-561.
    >> Share

  10. MANTI S, Giallongo A, Parisi GF, Papale M, et al
    Combining biologics and CFTR modulators is safe: A pilot, observational, monocenter study.
    Pediatr Pulmonol. 2024;59:801-804.
    >> Share

  11. CURATOLA A, Corona F, Squillaci D, Saccari A, et al
    Lung ultrasound evaluation in people with cystic fibrosis: A new approach in the pulmonology outpatient clinic.
    Pediatr Pulmonol. 2024;59:592-599.
    >> Share

    February 2024
  12. BHATIA H, Bhatia A, Mathew JL, Saxena AK, et al
    Tracheobronchial abnormalities on computed tomography angiography in children with congenital heart disease.
    Pediatr Pulmonol. 2024 Feb 20. doi: 10.1002/ppul.26934.
    >> Share

  13. LEON-ASTUDILLO C, Brooks O, Salabarria SM, Coker M, et al
    Longitudinal changes of swallowing safety and efficiency in infants with spinal muscular atrophy who received disease modifying therapies.
    Pediatr Pulmonol. 2024 Feb 15. doi: 10.1002/ppul.26919.
    >> Share

  14. BUENDIA JA, Acuna-Cordero R, Rodriguez-Martinez CE
    Exploratory analysis of the economically justifiable price of nirsevimab for healthy late-preterm and term infants in Colombia.
    Pediatr Pulmonol. 2024 Feb 15. doi: 10.1002/ppul.26920.
    >> Share

  15. LAHIRI T, VanNostrand J, Faricy L, Twichell S, et al
    Profound electrolyte and acid-base disturbances in an infant with cystic fibrosis.
    Pediatr Pulmonol. 2024 Feb 15. doi: 10.1002/ppul.26924.
    >> Share

  16. NOBILE S, Sbordone A, Salce N, Patti ML, et al
    Diaphragm atrophy during invasive mechanical ventilation is related to extubation failure in preterm infants: An ultrasound study.
    Pediatr Pulmonol. 2024 Feb 14. doi: 10.1002/ppul.26818.
    >> Share

  17. DASSIOS T, Vervenioti A, Tsintoni A, Fouzas S, et al
    Flow-resistive loading and diaphragmatic muscle function in term and preterm infants.
    Pediatr Pulmonol. 2024 Feb 14. doi: 10.1002/ppul.26899.
    >> Share

  18. EL-FARAMAWY A, Nasr SZ, Emam MMSA, Fahmy HMH, et al
    Clinical and genetic risk factors for cystic fibrosis-related liver disease in Egyptian CF children: A single-center experience.
    Pediatr Pulmonol. 2024;59:465-471.
    >> Share

  19. PLATT T, Kormelink LN, Autry EB, Rossoll SJ, et al
    Assessment of long-term medication adherence with cystic fibrosis: An integrated approach.
    Pediatr Pulmonol. 2024;59:458-464.
    >> Share

  20. WRIGHT BA, Knockel LM
    Unlocking the power of pharmacy services and accelerating access to medications: An update to the impact of pharmacy services on cystic fibrosis transmembrane conductance regulator modulator prescribing at a pediatric cystic fibrosis center.
    Pediatr Pulmonol. 2024;59:526-527.
    >> Share

  21. TIWARI SK, Sharma R, Joshi P, Lodha R, et al
    Knowledge, attitude, and practices among caregivers of children with Cystic Fibrosis.
    Pediatr Pulmonol. 2024;59:449-457.
    >> Share

  22. STEUART R, Pan AY, Woolums A, Benscoter D, et al
    Respiratory culture growth and 3-years lung health outcomes in children with bronchopulmonary dysplasia and tracheostomies.
    Pediatr Pulmonol. 2024;59:300-313.
    >> Share

  23. COLLACO JM, Tsukahara KR, Tracy MC, Sheils CA, et al
    Number of children in the household influences respiratory morbidities in children with bronchopulmonary dysplasia in the outpatient setting.
    Pediatr Pulmonol. 2024;59:314-322.
    >> Share

    January 2024
  24. DIRICKX M, Vermeulen F, Boon M, Debeer A, et al
    Multiple breath washout measurements in school aged patients with congenital diaphragmatic hernia.
    Pediatr Pulmonol. 2024 Jan 30. doi: 10.1002/ppul.26888.
    >> Share

  25. ZIREK F, Ozcan G, Tekin MN, Ucar CI, et al
    An infant with episodic stridor and respiratory crises since birth: A challenging diagnosis.
    Pediatr Pulmonol. 2024 Jan 22. doi: 10.1002/ppul.26866.
    >> Share

  26. AMITAI N, Stafler P, Blau H, Kaplan E, et al
    Cardiopulmonary exercise testing in adolescence following extremely premature birth.
    Pediatr Pulmonol. 2024 Jan 19. doi: 10.1002/ppul.26867.
    >> Share

  27. KOUCKY V, Martinu V, Koucky M
    Impaired lung function in infants with primary ciliary dyskinesia: A pilot Czech study.
    Pediatr Pulmonol. 2024 Jan 11. doi: 10.1002/ppul.26863.
    >> Share

  28. KIMURA S, Toyoshima K, Shimokaze T, Katsumata K, et al
    Respiratory function testing for guiding ventilator mode conversion in congenital diaphragmatic hernia.
    Pediatr Pulmonol. 2024 Jan 11. doi: 10.1002/ppul.26789.
    >> Share

  29. MILESI C, Nogue E, Baleine J, Moulis L, et al
    ROX (Respiratory rate-OXygenation) index to predict early response to high-flow nasal cannula therapy in infants with viral bronchiolitis.
    Pediatr Pulmonol. 2024 Jan 10. doi: 10.1002/ppul.26860.
    >> Share

  30. MADANI KIA T, McKinney M, Dicken B, Thompson A, et al
    Clinical curiosity: How long should we wait? Management of ventilator associated pneumatocele in an extremely preterm infant.
    Pediatr Pulmonol. 2024 Jan 9. doi: 10.1002/ppul.26834.
    >> Share

  31. YASA B, Kersin SG, Cetinkaya M, Ozek E, et al
    Regional pulmonary oxygen saturations in late preterm and term infants with respiratory distress at birth.
    Pediatr Pulmonol. 2024 Jan 5. doi: 10.1002/ppul.26849.
    >> Share

  32. LEVY Y, Bitton L, Sileo C, Rambaud J, et al
    Lung biopsies in infants and children in critical care situation.
    Pediatr Pulmonol. 2024 Jan 2. doi: 10.1002/ppul.26845.
    >> Share

  33. SHAH K, Schindler T, Myers RE, Sankararaman S, et al
    Pancreatic cystosis in cystic fibrosis.
    Pediatr Pulmonol. 2024;59:210-212.
    >> Share

  34. LEE J, Husami A, Arora K, Zhang W, et al
    A personalized medicine approach to optimize care for a pediatric cystic fibrosis patient with atypical clinical symptoms.
    Pediatr Pulmonol. 2024;59:229-232.
    >> Share

  35. HANGER S, Felton I, Ukor EF, Bowman E, et al
    The effectiveness of CFTR modulators in people with CF and rare mutations: A real-world study.
    Pediatr Pulmonol. 2024;59:221-224.
    >> Share

  36. HJELM M, Hente E, Schuler CL, Duan Q, et al
    Education-related needs for children with cystic fibrosis: Perspectives of US pediatric care teams.
    Pediatr Pulmonol. 2024;59:95-100.
    >> Share

  37. LINDLEY B, Bhakta Z, Leclair L, Young DC, et al
    The pharmacokinetics and pharmacodynamics of continuous infusion vancomycin in adult people with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:89-94.
    >> Share

  38. KOW S, Rieger B, Morse K, Keens T, et al
    The positive impact of journaling on adolescents with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:63-71.
    >> Share

    December 2023
  39. GAYOSO-LIVIAC MG, Nino G, Montgomery AS, Hong X, et al
    Infants hospitalized with lower respiratory tract infections during the first two years of life have increased risk of pediatric obstructive sleep apnea.
    Pediatr Pulmonol. 2023 Dec 28. doi: 10.1002/ppul.26810.
    >> Share

  40. CORCORAN A, Faig W, Ren CL
    Clinical features associated with pulmonary exacerbation diagnosis in infants and young children with cystic fibrosis.
    Pediatr Pulmonol. 2023 Dec 22. doi: 10.1002/ppul.26838.
    >> Share

  41. KATO M, Mochizuki H, Kama Y, Kusuda S, et al
    Palivizumab prophylaxis in preterm infants and subsequent wheezing/asthma: 10-year follow-up study.
    Pediatr Pulmonol. 2023 Dec 20. doi: 10.1002/ppul.26824.
    >> Share

  42. STOFFELLA S, Ly N, McGarry M, Neemuchwala F, et al
    Cystic fibrosis transmembrane conductance regulator modulator administration to a F508del heterozygous infant with meconium pseudocyst and short bowel syndrome: A case report.
    Pediatr Pulmonol. 2023 Dec 13. doi: 10.1002/ppul.26809.
    >> Share

  43. SENA CRDS, Morten M, Collison AM, Shaar A, et al
    Bronchiolitis hospital admission in infancy is associated with later preschool ventilation inhomogeneity.
    Pediatr Pulmonol. 2023 Dec 13. doi: 10.1002/ppul.26793.
    >> Share

  44. ELIJAH J, Fitzgerald LJ, Phan H
    Use of CFTR modulators in special populations, part 1: Pregnancy and lactation.
    Pediatr Pulmonol. 2023;58:3377-3385.
    >> Share

  45. ELIJAH J, Fitzgerald LJ, Phan H
    Use of CFTR modulators in special populations, part 2: Severe lung disease.
    Pediatr Pulmonol. 2023;58:3386-3392.
    >> Share

  46. TEPER A, Lubovich S, Rodriguez V, Zaragoza S, et al
    Real-life experience with a generic formulation of lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for the Phe508del CFTR mutation.
    Pediatr Pulmonol. 2023;58:3560-3565.
    >> Share

  47. LEBECQUE P, Thimmesch M, Meurrens J, Jeanmart P, et al
    Cystic fibrosis: Does it matter to avoid crushing Elexacaftor/Tezacaftor/Ivacaftor (ETI) tablets?
    Pediatr Pulmonol. 2023;58:3603-3604.
    >> Share

  48. ZHANG R, Sun Y
    A Chinese pediatric cystic fibrosis patient with the c.1624G>T, p. Gly542x/c.223C>T, p. Arg75x genotype.
    Pediatr Pulmonol. 2023;58:3619-3621.
    >> Share

  49. ANDERTON KA, Christensen R, Zobell JT
    Impact of pharmacy services on people with cystic fibrosis (PwCF) immunization rates.
    Pediatr Pulmonol. 2023;58:3622-3625.
    >> Share

  50. MANCIULLI T, Bresci S, Mencarini J, Avarello A, et al
    Prevalence of adverse events in cystic fibrosis patients treated with elexacaftor/tezacaftor/ivacaftor: Experience of the regional referral center in Tuscany, Italy.
    Pediatr Pulmonol. 2023;58:3626-3629.
    >> Share

  51. BLANCO-ORIVE P, Del Corral T, Martin-Casas P, Cebria I Iranzo MA, et al
    Spanish adaptation and validation of the child- and parent-report cystic fibrosis questionnaire-revised (CFQ-R).
    Pediatr Pulmonol. 2023;58:3447-3457.
    >> Share

  52. KADOUH NK, Elijah J, Fitzgerald LJ, Phan H, et al
    Use of CFTR modulators in special populations, part 3: Solid organ transplant.
    Pediatr Pulmonol. 2023;58:3393-3402.
    >> Share

  53. DUNCAN DR, Golden C, Larson K, Williams N, et al
    Breastfeeding in infants who aspirate may increase risk of pulmonary inflammation.
    Pediatr Pulmonol. 2023 Dec 1. doi: 10.1002/ppul.26788.
    >> Share

  54. LIPTZIN DR, McGraw MD, Stidham T, Wambach JA, et al
    Noninvasive management of infants with SFTPC pathogenic variants.
    Pediatr Pulmonol. 2023 Dec 1. doi: 10.1002/ppul.26722.
    >> Share

    November 2023
  55. KIPFMUELLER F, Leyens J, Pugnaloni F, Bo B, et al
    Spontaneous breathing in selected neonates with very mild congenital diaphragmatic hernia.
    Pediatr Pulmonol. 2023 Nov 29. doi: 10.1002/ppul.26791.
    >> Share

  56. GUSTAFSON B, Pinto S
    A unique case of pneumocystis pneumonia in infancy.
    Pediatr Pulmonol. 2023 Nov 28. doi: 10.1002/ppul.26776.
    >> Share

  57. SCHROEDER L, Pommer K, Geipel A, Strizek B, et al
    A comparative analysis of the Vasoactive-Inotropic Score, the Vasoactive-Ventilation-Renal Score, and the Oxygenation Index as outcome predictors in infants with a congenital diaphragmatic hernia.
    Pediatr Pulmonol. 2023 Nov 28. doi: 10.1002/ppul.26785.
    >> Share

  58. ZHU Z, He Y, Yuan L, Chen L, et al
    Trends in bronchopulmonary dysplasia and respiratory support among extremely preterm infants in China over a decade.
    Pediatr Pulmonol. 2023 Nov 28. doi: 10.1002/ppul.26761.
    >> Share

  59. OESTREICH MA, Hanni R, Wyler F, Kentgens AC, et al
    Comparison of functional residual capacity between updated infant SF(6) multiple-breath washout setups.
    Pediatr Pulmonol. 2023 Nov 27. doi: 10.1002/ppul.26770.
    >> Share

  60. JANUSKA MN, Langfelder-Schwind E, Vicencio AG, Berdella MN, et al
    Persistent lobar atelectasis in an infant with cystic fibrosis: The role for flexible bronchoscopy and poractant alfa.
    Pediatr Pulmonol. 2023 Nov 17. doi: 10.1002/ppul.26757.
    >> Share

  61. WENDEL K, Rossholt ME, Gunnarsdottir G, Aas MF, et al
    Lung function in preterm infants at 3 months corrected age after neonatal LC-PUFA supplementation.
    Pediatr Pulmonol. 2023 Nov 17. doi: 10.1002/ppul.26760.
    >> Share

  62. TSOI SM, Nawaytou H, Almeneisi H, Steurer M, et al
    Prostaglandin-E1 infusion in persistent pulmonary hypertension of the newborn.
    Pediatr Pulmonol. 2023 Nov 17. doi: 10.1002/ppul.26759.
    >> Share

  63. THOMANN J, Gaertner VD, Waldmann AD, Plastina L, et al
    Nasal high frequency oscillatory highflow therapy in preterm infants: A randomized crossover trial.
    Pediatr Pulmonol. 2023 Nov 8. doi: 10.1002/ppul.26748.
    >> Share

  64. GUSTAFSON B, Britt RD Jr, Eisner M, Narayanan D, et al
    Predictors of recurrent wheezing in late preterm infants.
    Pediatr Pulmonol. 2023 Nov 3. doi: 10.1002/ppul.26739.
    >> Share

  65. DONADIO MVF, Barbosa MA, Vendrusculo FM, Ramirez TI, et al
    Mechanisms of ventilatory limitation to maximum exercise in children and adolescents with chronic airway diseases.
    Pediatr Pulmonol. 2023;58:3293-3302.
    >> Share

  66. GUR M, Manor E, Hanna M, Simaan N, et al
    The effect of inspiratory muscle training in PCD and CF patients: A pilot study.
    Pediatr Pulmonol. 2023;58:3264-3270.
    >> Share

  67. KIM J, Lyman B, Savant AP
    Cystic fibrosis year in review 2022.
    Pediatr Pulmonol. 2023;58:3013-3022.
    >> Share

  68. MONDEJAR-LOPEZ P, Moreno-Galarraga L, de Manuel-Gomez C, Blitz-Castro E, et al
    SARS-CoV-2 infection in children with cystic fibrosis: A cross-sectional multicenter study in Spain. New waves, new knowledge.
    Pediatr Pulmonol. 2023;58:3195-3205.
    >> Share

  69. STRATI MF, Bassi M, Pescini R, Ciprandi R, et al
    Mixed educational camps for children and adolescents with type 1 diabetes and cystic fibrosis: A new therapeutic alliance.
    Pediatr Pulmonol. 2023;58:3346-3348.
    >> Share

  70. FOUZAS S, Kogias C, Gioulvanidou M, Bertzouanis A, et al
    Low-frequency oscillometry indices to assess ventilation inhomogeneity in CF patients.
    Pediatr Pulmonol. 2023;58:3147-3155.
    >> Share

  71. MOHAN M, Mannil A, Chandrasekaran V, Gulati R, et al
    Normative data for aquagenic wrinkling of palms in children 1-15 years of age: A cross-sectional study.
    Pediatr Pulmonol. 2023;58:3133-3138.
    >> Share

  72. HUANG L, Lai HJ, Song J, Zhao Z, et al
    Impact of intrinsic and extrinsic risk factors on early-onset lung disease in cystic fibrosis.
    Pediatr Pulmonol. 2023;58:3071-3082.
    >> Share

    October 2023
  73. BALDWIN K, Barker EM, Carayannopoulos M, Farrell PM, et al
    Severe lung disease in children with cystic fibrosis missed in newborn screening.
    Pediatr Pulmonol. 2023 Oct 27. doi: 10.1002/ppul.26734.
    >> Share

  74. GOUSSARD P, van Wyk L, Venkatakrishna S, Andronikou S, et al
    Removal of bronchial foreign body in a ventilated preterm infant with flexible bronchoscopy.
    Pediatr Pulmonol. 2023 Oct 20. doi: 10.1002/ppul.26731.
    >> Share

  75. SCHOLTEN AWJ, Zhan Z, Niemarkt HJ, Vervoorn M, et al
    Cardiorespiratory monitoring with a wireless and nonadhesive belt measuring diaphragm activity in preterm and term infants: A multicenter non-inferiority study.
    Pediatr Pulmonol. 2023 Oct 5. doi: 10.1002/ppul.26695.
    >> Share

  76. GILTMIER AJ, Higano NS, Woods JC, Kingma PS, et al
    Evaluation of regional lung mass and growth in neonates with bronchopulmonary dysplasia using ultrashort echo time magnetic resonance imaging.
    Pediatr Pulmonol. 2023 Oct 3. doi: 10.1002/ppul.26705.
    >> Share

  77. EDMONDSON C, Westrupp N, Short C, Seddon P, et al
    Unsupervised home spirometry is not equivalent to supervised clinic spirometry in children and young people with cystic fibrosis: Results from the CLIMB-CF study.
    Pediatr Pulmonol. 2023;58:2871-2880.
    >> Share

  78. XU C, Tang Y, Dong L, Shen Y, et al
    Clinical and genetic characteristics of children with cystic fibrosis in Henan China: A single-center retrospective analysis.
    Pediatr Pulmonol. 2023;58:2865-2870.
    >> Share

  79. CONLON S, Glenn T
    Less invasive surfactant administration: Fine tuning a disparate practice.
    Pediatr Pulmonol. 2023;58:2701-2702.
    >> Share

  80. GATT D, Shaw M, Waters V, Kritzinger F, et al
    Treatment response to pulmonary exacerbation in primary ciliary dyskinesia.
    Pediatr Pulmonol. 2023;58:2857-2864.
    >> Share

  81. SHANTHIKUMAR S, Ruseckaite R, Corda J, Mulrennan S, et al
    Telehealth use in Australian cystic fibrosis centers: Clinician experiences.
    Pediatr Pulmonol. 2023;58:2906-2915.
    >> Share

  82. GALAMBOS C, Logan JW, Stankiewicz P, Szafranski P, et al
    Histologic features and decreased lung FOXF1 gene expression in severe bronchopulmonary dysplasia without a genetic diagnosis of alveolar capillary dysplasia.
    Pediatr Pulmonol. 2023;58:2746-2749.
    >> Share

    September 2023
  83. SHANDIL A, Bhatia A, Mathew JL, Saxena AK, et al
    Unilateral bilobar pulmonary aplasia with anomalous pulmonary venous return: A rare combination of congenital airway and vascular anomalies.
    Pediatr Pulmonol. 2023 Sep 20. doi: 10.1002/ppul.26697.
    >> Share

  84. STALKER HJ, Jonasson AR, Hopfer SM, Collins MS, et al
    Improvement in cystic fibrosis newborn screening program outcomes with genetic counseling via telemedicine.
    Pediatr Pulmonol. 2023 Sep 15. doi: 10.1002/ppul.26678.
    >> Share

  85. LI H, Huang Z, Yang C, Han D, et al
    Association between plasma lysophosphatidic acid levels and bronchopulmonary dysplasia in extremely preterm infants: A prospective study.
    Pediatr Pulmonol. 2023 Sep 15. doi: 10.1002/ppul.26685.
    >> Share

  86. HUANG Z, Cheng X, Lin B, Zhao J, et al
    Diameter of ductus arteriosus on postnatal Day 7 is associated with late pulmonary hypertension in extremely preterm infants.
    Pediatr Pulmonol. 2023 Sep 15. doi: 10.1002/ppul.26686.
    >> Share

  87. VITALE JL, DeMauro SB, Gibbs K, Kielt MJ, et al
    Clinician opinions on nasal versus oral intubation in infants with BPD: A multicenter survey.
    Pediatr Pulmonol. 2023 Sep 13. doi: 10.1002/ppul.26653.
    >> Share

  88. COUSINS M, Hart K, Radics BL, Henderson AJ, et al
    Peripheral airway dysfunction in prematurity-associated obstructive lung disease identified by oscillometry.
    Pediatr Pulmonol. 2023 Sep 13. doi: 10.1002/ppul.26658.
    >> Share

  89. RUFFLES T, Inglis SK, Memon A, Seddon P, et al
    Environmental risk factors for respiratory infection and wheeze in young children: A multicentre birth cohort study.
    Pediatr Pulmonol. 2023 Sep 10. doi: 10.1002/ppul.26664.
    >> Share

  90. FINN E, Severn C, Pyle L, Garrish J, et al
    Hypoglycemia in children and young adults with cystic fibrosis during oral glucose tolerance testing vs. continuous glucose monitoring.
    Pediatr Pulmonol. 2023;58:2495-2504.
    >> Share

  91. EKBLOND RS, Nielsen BU, Hojte C, Almdal TP, et al
    Changes in glucose tolerance in people with cystic fibrosis after initiation of first-generation CFTR modulator treatment.
    Pediatr Pulmonol. 2023;58:2600-2609.
    >> Share

  92. HERGENROEDER GE, Faino AV, Cogen JD, Genatossio A, et al
    Seroprevalence and clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:2478-2486.
    >> Share

  93. DEPIAZZI J, Bourke C, Stick S, Withers A, et al
    Prevalence of tracheobronchomalacia is higher than previously reported in children with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:2568-2573.
    >> Share

  94. RICHARDS CJ, Friedman D, Pinsky H, Gootkind E, et al
    Alcohol and opiate misuse in adults with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:2535-2542.
    >> Share

  95. IFIKHAR J, Hendrix-Dicken AD, Kezbers KM, Stuemky L, et al
    Cystic fibrosis fitness during inpatient treatment (CF-FIT): A pre-post pilot study.
    Pediatr Pulmonol. 2023;58:2675-2677.
    >> Share

  96. UYTUN S, Cinel G, Eryilmaz Polat S, Ozkan Tabakci S, et al
    Patients with cystic fibrosis who could not receive the CFTR modulator treatment: What did they lose in 1 year?
    Pediatr Pulmonol. 2023;58:2505-2512.
    >> Share

  97. BATHGATE CJ, Muther E, Georgiopoulos AM, Smith B, et al
    Positive and negative impacts of elexacaftor/tezacaftor/ivacaftor: Healthcare providers' observations across US centers.
    Pediatr Pulmonol. 2023;58:2469-2477.
    >> Share

    August 2023
  98. PUGH CP, Ali S, Agarwal A, Matlock DN, et al
    Dynamic computed tomography for evaluation of tracheobronchomalacia in premature infants with bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2023 Aug 30. doi: 10.1002/ppul.26652.
    >> Share

  99. OZDEMIR FE, Alan S, Aliefendioglu D
    The diagnostic value of pulmonary near-infrared spectroscopy in the early distinction of neonatal pneumonia from transient tachypnea of the newborn.
    Pediatr Pulmonol. 2023 Aug 30. doi: 10.1002/ppul.26656.
    >> Share

  100. HAGMAN C, Bjorklund LJ, Bjermer L, Hansen-Pupp I, et al
    Lung function deficits and bronchodilator responsiveness at 12 years of age in children born very preterm compared with controls born at term.
    Pediatr Pulmonol. 2023 Aug 18. doi: 10.1002/ppul.26636.
    >> Share

  101. CORREANI A, Lanciotti L, Giorgetti C, Palazzi ML, et al
    Reduced pulmonary oxygen diffusion at 36 weeks of postmenstrual age in small-for-gestational-age preterm infants of less than 32 weeks without bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2023 Aug 18. doi: 10.1002/ppul.26620.
    >> Share

  102. SMITH EF, Bradshaw TK, Urs RC, Evans DJ, et al
    Oscillometry and spirometry are not interchangeable when assessing the bronchodilator response in children and young adults born preterm.
    Pediatr Pulmonol. 2023 Aug 4. doi: 10.1002/ppul.26632.
    >> Share

  103. DEY R, Sardar SK, Kumar Saha A, Mukherjee S, et al
    Nonsynchronized nasal intermittent positive pressure ventilation versus continuous positive airway pressure as a primary mode of respiratory support in neonates (26-40 weeks) admitted in a tertiary care center: A randomized controlled trial.
    Pediatr Pulmonol. 2023 Aug 2. doi: 10.1002/ppul.26624.
    >> Share

  104. GUPTA R, Bandyopadhyay T, Yadav B, Guleria M, et al
    Sonographic assessment of diaphragmatic thickness and excursion to predict CPAP failure in neonates below 34 weeks of gestation: A prospective cohort study.
    Pediatr Pulmonol. 2023 Aug 2. doi: 10.1002/ppul.26608.
    >> Share

  105. SISMANLAR EYUBOGLU T, Aslan AT, Asfuroglu P, Kunt N, et al
    Neutrophil lymphocyte ratio, mean platelet volume, and immunoreactive trypsinogen as early inflammatory biomarkers for cystic fibrosis in infancy: A retrospective cohort study.
    Pediatr Pulmonol. 2023 Aug 2. doi: 10.1002/ppul.26628.
    >> Share

  106. GOETZ DM, Frederick CK, Perez G, Borowitz D, et al
    Airway clearance after highly effective CFTR modulators: Normalizing life and reducing treatment burden.
    Pediatr Pulmonol. 2023;58:2375-2380.
    >> Share

  107. SOUTH K, Smaldone A, Sadeghi H, Piane V, et al
    Parent and adolescent perceptions of cystic fibrosis management responsibility: A mixed-methods study.
    Pediatr Pulmonol. 2023;58:2340-2351.
    >> Share

  108. GUSHUE C, Eisner M, Bai S, Johnson T, et al
    Impact of Elexacaftor-Tezacaftor-Ivacaftor on lung disease in cystic fibrosis.
    Pediatr Pulmonol. 2023;58:2308-2316.
    >> Share

  109. PALLA J, Thapa S, Venkatachalam A, Runge JK, et al
    The upper airway microbiome in Hispanic children with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:2298-2307.
    >> Share

  110. AALBERS BL, Mohamed Hoesein FAA, Hofland RW, Bronsveld I, et al
    Radiological and long-term clinical response to elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease.
    Pediatr Pulmonol. 2023;58:2317-2322.
    >> Share

  111. DAY RW, Lai KV, Baisch HN, Lau IC, et al
    Descriptive images and features of pulmonary vascular disease in a child with a FOXF1 variant.
    Pediatr Pulmonol. 2023;58:2383-2385.
    >> Share

  112. SOHOULI MH, Magalhaes EIDS, Ghahramani S, Nasresfahani M, et al
    Impact of omega-3 supplementation on children and adolescents patients with cystic fibrosis: A systematic review and meta-analysis of randomized-controlled trials.
    Pediatr Pulmonol. 2023;58:2219-2228.
    >> Share

  113. CORDA J, E Holland A, Berry CD, Westrupp N, et al
    Validation of the 25 level modified shuttle test in children with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:2240-2248.
    >> Share

    July 2023
  114. ROCK MJ, Baker M, Farrell PM
    Cystic fibrosis screen-positive neonates with one pathogenic variant still warrant sweat testing.
    Pediatr Pulmonol. 2023 Jul 28. doi: 10.1002/ppul.26621.
    >> Share

  115. ABE J, Ueki M, Honjou R, Takeda K, et al
    The clinical importance of pulmonary gene and protein expression levels in an infant with lethal ABCA3 variants.
    Pediatr Pulmonol. 2023 Jul 21. doi: 10.1002/ppul.26611.
    >> Share

  116. VILLAMIL-OSORIO M, Moyano-Ariza LF, Camacho-Moreno G, Restrepo-Gualteros SM, et al
    Multilevel analysis identifying the factors associated with RSV detection in infants admitted for viral bronchiolitis in the era of the COVID-19 pandemic.
    Pediatr Pulmonol. 2023 Jul 14. doi: 10.1002/ppul.26590.
    >> Share

  117. MOHSEN N, Solis-Garcia G, Jasani B, Nasef N, et al
    Accuracy of lung ultrasound in predicting extubation failure in neonates: A systematic review and meta-analysis.
    Pediatr Pulmonol. 2023 Jul 11. doi: 10.1002/ppul.26598.
    >> Share

  118. WU C, Fu J, Zhu X, Li H, et al
    Heart failure due to pulmonary sequestration in an infant.
    Pediatr Pulmonol. 2023 Jul 11. doi: 10.1002/ppul.26596.
    >> Share

  119. PERRI A, Sbordone A, Patti ML, Nobile S, et al
    The future of neonatal lung ultrasound: Validation of an artificial intelligence model for interpreting lung scans. A multicentre prospective diagnostic study.
    Pediatr Pulmonol. 2023 Jul 7. doi: 10.1002/ppul.26563.
    >> Share

  120. VERKLEIJ M, Georgiopoulos AM, Barendrecht H, Friedman D, et al
    Pilot of a therapist-guided digital mental health intervention (eHealth CF-CBT) for adults with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:2094-2103.
    >> Share

  121. TERLIZZI V, Fevola C, Ferrari B, Castellani C, et al
    Lung clearance index in children with cystic fibrosis previously diagnosed with CRMS/CFSPID: A monocentric prospective experience.
    Pediatr Pulmonol. 2023;58:2124-2131.
    >> Share

  122. FOSTER C, Noreen P, Grage J, Kwon S, et al
    Predictors for invasive home mechanical ventilation duration in bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2023;58:2085-2093.
    >> Share

  123. WARD A, Mauleon R, Arellano J, Ooi CY, et al
    Critical disease burdens of Australian adults with cystic fibrosis: Results from an online survey.
    Pediatr Pulmonol. 2023;58:1931-1941.
    >> Share

  124. KIMBALL H, Cobham VE, Sanders M, Douglas T, et al
    Procedural anxiety among children and adolescents with cystic fibrosis and their parents.
    Pediatr Pulmonol. 2023;58:1967-1976.
    >> Share

  125. PRIYADARSHI M, Sankar MJ
    Lung ultrasound for surfactant replacement: Methodological concerns.
    Pediatr Pulmonol. 2023;58:1864-1865.
    >> Share

  126. FEIN V, Maier C, Schlegtendal A, Denz R, et al
    Risk factors for the deterioration of pulmonary function in primary ciliary dyskinesia.
    Pediatr Pulmonol. 2023;58:1950-1958.
    >> Share

  127. HUNTER-SCHOUELA J, Geraghty MT, Hegele RA, Dyment DA, et al
    First reports of primary ciliary dyskinesia caused by a shared DNAH11 allele in Canadian Inuit.
    Pediatr Pulmonol. 2023;58:1942-1949.
    >> Share

  128. NOIJ L, Haarman E, Hashimoto S, Terheggen-Lagro S, et al
    Depression, anxiety, and resilience during COVID-19 in Dutch patients with cystic fibrosis or primary ciliary dyskinesia and their caregivers.
    Pediatr Pulmonol. 2023;58:2025-2034.
    >> Share

    June 2023
  129. MENG CY, Zou JZ, Wang Y, Wei YD, et al
    Pathological findings in congenital diaphragmatic hernia on necropsy studies: A single-center case series.
    Pediatr Pulmonol. 2023 Jun 28. doi: 10.1002/ppul.26565.
    >> Share

  130. VIVALDA L, Loi B, Bisceglie V, Ben-Ammar R, et al
    Effect of preterm chorioamnionitis on lung ultrasound score used to guide surfactant replacement.
    Pediatr Pulmonol. 2023 Jun 28. doi: 10.1002/ppul.26576.
    >> Share

  131. LAVIZZARI A, Zannin E, Klotz D, Dassios T, et al
    State of the art on neonatal noninvasive respiratory support: How physiological and technological principles explain the clinical outcomes.
    Pediatr Pulmonol. 2023 Jun 28. doi: 10.1002/ppul.26561.
    >> Share

  132. KRISHNANANTHAN T, Britton PN, Wong M, Selvadurai H, et al
    COVID-19 complicated by postinfectious bronchiolitis obliterans and pulmonary aspergillosis in an infant.
    Pediatr Pulmonol. 2023 Jun 23. doi: 10.1002/ppul.26572.
    >> Share

  133. AOYAMA BC, McGrath-Morrow SA, Psoter KJ, Collaco JM, et al
    Patterns of early life somatic growth in infants and children with a history of chronic lung disease of prematurity.
    Pediatr Pulmonol. 2023 Jun 23. doi: 10.1002/ppul.26560.
    >> Share

  134. TSUKAHARA K, Scully T, McDonough J, Boas H, et al
    Reactance inversion in a cohort of former preterms: Physiology or artifact?
    Pediatr Pulmonol. 2023 Jun 21. doi: 10.1002/ppul.26553.
    >> Share

  135. KIPFMUELLER F, Bo B, Schmitt J, Sabir H, et al
    Percutaneous, ultrasound-guided single- and multisite cannulation for veno-venous extracorporeal membrane oxygenation in neonates.
    Pediatr Pulmonol. 2023 Jun 14. doi: 10.1002/ppul.26555.
    >> Share

  136. HU H, Jing X, Duan X, Zhou L, et al
    Congenital diaphragmatic hernia.
    Pediatr Pulmonol. 2023 Jun 14. doi: 10.1002/ppul.26542.
    >> Share

  137. CHEN Y, Zhang Y
    Extremely thinning ribs in severe congenital myopathy.
    Pediatr Pulmonol. 2023 Jun 14. doi: 10.1002/ppul.26547.
    >> Share

  138. SHEN J, Du Y, Sun Y, Huang X, et al
    Modified lung ultrasound score for bronchopulmonary dysplasia predicts late respiratory outcomes in preterm infants.
    Pediatr Pulmonol. 2023 Jun 9. doi: 10.1002/ppul.26546.
    >> Share

  139. LUSTEAU A, Valla F, Javouhey E, Baudin F, et al
    Hypophosphatemia in infants with severe bronchiolitis and association with length of mechanical ventilation.
    Pediatr Pulmonol. 2023 Jun 6. doi: 10.1002/ppul.26538.
    >> Share

  140. MARCELINO M, Cai CL, Wadowski S, Aranda JV, et al
    Biomarkers of lung alveolarization and microvascular maturation in response to intermittent hypoxia and/or early antioxidant/fish oil supplementation in neonatal rats.
    Pediatr Pulmonol. 2023 Jun 2. doi: 10.1002/ppul.26495.
    >> Share

  141. ZONG H, Huang Y, Huang Z, Zhao J, et al
    Lung ultrasound score predicts patent ductus arteriosus ligation among neonates
    Pediatr Pulmonol. 2023 Jun 2. doi: 10.1002/ppul.26531.
    >> Share

  142. KIELT MJ, Hatch LD 3rd, Levin JC, Napolitano N, et al
    Classifying multicenter approaches to invasive mechanical ventilation for infants with bronchopulmonary dysplasia using hierarchical clustering analysis.
    Pediatr Pulmonol. 2023 Jun 2. doi: 10.1002/ppul.26488.
    >> Share

  143. CHIN D, Ramalingam L, Harrison J, Silva M, et al
    Oral health and cystic fibrosis in pediatrics: A survey of health professionals.
    Pediatr Pulmonol. 2023;58:1746-1752.
    >> Share

  144. SALLIH ASM, Wee MW, Zaki RA, Hng SY, et al
    The outcome of COVID-19 in children with chronic lung disease: Systematic review and meta-analyses.
    Pediatr Pulmonol. 2023;58:1784-1797.
    >> Share

  145. QUITTNER AL, Barker D, Graziano S, Georgiopoulos AM, et al
    National integration of mental health screening and treatment into specialized care for cystic fibrosis: What predicts success?
    Pediatr Pulmonol. 2023;58:1768-1776.
    >> Share

  146. RAISSI G, Messier R, Sadeghi D, Sadeghi H, et al
    CF Bridge of Hope program, a global medical home practice.

    Pediatr Pulmonol. 2023;58:1802-1804.
    >> Share

  147. GRANADOS A, Chan CL, Moheet A, Vigers T, et al
    The impact of elexacaftor/tezacaftor/ivacaftor on body composition in a small cohort of youth with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:1805-1811.
    >> Share

  148. PERKINS RC, Sawicki GS
    High deductible insurance plans impart economic burden for people with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:1798-1801.
    >> Share

    May 2023
  149. HON KLE, Hui CMP, Fung GPG, Leung KKY, et al
    Hypertonic glucose pleurodesis for preterm neonates with chylothorax.
    Pediatr Pulmonol. 2023 May 12. doi: 10.1002/ppul.26436.
    >> Share

  150. WU S, Ryan RM, Auten RL
    2022 Year in review: Neonatal pulmonology.
    Pediatr Pulmonol. 2023 May 12. doi: 10.1002/ppul.26468.
    >> Share

  151. KOJIMA M, Touge R, Kurihara S, Saeki I, et al
    Transthoracic puncture for asymptomatic congenital pulmonary airway malformation during anesthesia.
    Pediatr Pulmonol. 2023 May 10. doi: 10.1002/ppul.26469.
    >> Share

  152. DANI C, Fusco M, Manti S, Marseglia L, et al
    Effects of caffeine on diaphragmatic activity in preterm infants.
    Pediatr Pulmonol. 2023 May 5. doi: 10.1002/ppul.26439.
    >> Share

  153. HARRIS C, Lunt A, Peacock J, Greenough A, et al
    Lung function at 16-19 years in males and females born very prematurely.
    Pediatr Pulmonol. 2023 May 5. doi: 10.1002/ppul.26428.
    >> Share

  154. CALLAWAY DA, Wang Y, Lingappan K, Pogoriler JE, et al
    Lung biopsy in infants with severe bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2023 May 3. doi: 10.1002/ppul.26433.
    >> Share

  155. CHOOBDAR FA, Shahhosseini P, Vahedi Z, Khosravi N, et al
    Comparison of the efficacy of inhaled versus infused milrinone in the management of persistent pulmonary hypertension of the newborn in resource-limited settings: A randomized clinical trial.
    Pediatr Pulmonol. 2023 May 3. doi: 10.1002/ppul.26451.
    >> Share

  156. BU X, Sun P, Wan Y
    Meconium thorax observed in a Chinese neonate with cystic fibrosis.
    Pediatr Pulmonol. 2023 May 3. doi: 10.1002/ppul.26443.
    >> Share

  157. DACCO V, Alicandro G, Consales A, Rosazza C, et al
    Cepacia syndrome in cystic fibrosis: A systematic review of the literature and possible new perspectives in treatment.
    Pediatr Pulmonol. 2023;58:1337-1343.
    >> Share

  158. SALAH S, Rumman N, Nassar A, Khdour M, et al
    Clinical characteristics and outcomes of cystic fibrosis in Palestine: Cross sectional study.
    Pediatr Pulmonol. 2023;58:1574-1581.
    >> Share

  159. STRANSKY OM, Benipal S, Pam M, Taylor-Cousar JL, et al
    "Find ways to work parenting into cystic fibrosis": A PhotoVoice exploration of being a parent and having CF.
    Pediatr Pulmonol. 2023;58:1527-1534.
    >> Share

  160. BECK MR, Hornick DB, Pena TA, Singh SB, et al
    Impact of elexacaftor/tezacaftor/ivacaftor on bacterial cultures from people with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:1569-1573.
    >> Share

  161. MCGLYNN JR, Aoyama BC, Martin A, Collaco JM, et al
    Outpatient respiratory outcomes in children with BPD on supplemental oxygen.
    Pediatr Pulmonol. 2023;58:1535-1541.
    >> Share

  162. COLLACO JM, Li Y, Rhein LM, Tracy MC, et al
    Validation of an outpatient questionnaire for bronchopulmonary dysplasia control.
    Pediatr Pulmonol. 2023;58:1551-1561.
    >> Share

  163. GECILI E, Brokamp C, Rasnick E, Afonso PM, et al
    Built environment factors predictive of early rapid lung function decline in cystic fibrosis.
    Pediatr Pulmonol. 2023;58:1501-1513.
    >> Share

  164. WALLACE K, Devenny A, Azam T, Langley RJ, et al
    Novel cystic fibrosis transmembrane conductance (CFTR) variant in a patient with Ghanaian parentage.
    Pediatr Pulmonol. 2023;58:1611-1613.
    >> Share

  165. KLEEBAYOON A, Wiwanitkit V
    Correspondence on acceptability of COVID-19 vaccination with bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2023;58:1610.
    >> Share

  166. BEDOYA M, Salfinger M, Weisman A, Colin AA, et al
    Culture result discrepancy between laboratories for nontuberculous mycobacteria in people with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:1598-1601.
    >> Share

  167. GOKDEMIR Y, Eralp EE, Ergenekon AP, Yegit CY, et al
    Improvements in body mass index of children with cystic fibrosis following implementation of a standardized nutritional algorithm: A quality improvement project.
    Pediatr Pulmonol. 2023;58:1463-1470.
    >> Share

  168. MCGARRY ME, Gibb ER, Laguna TA, O'Sullivan BP, et al
    How many billions is enough? Prioritizing profits over patients with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:1595-1597.
    >> Share

  169. DE VUYST RC, Bennard E, Kam CW, McKinzie CJ, et al
    Elexacaftor/tezacaftor/ivacaftor treatment reduces airway inflammation in cystic fibrosis.
    Pediatr Pulmonol. 2023;58:1592-1594.
    >> Share

  170. WANG D, Li L, Cao J, Hu S, et al
    Acceptability of COVID-19 vaccination in Chinese children aged 3-7 years with bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2023;58:1417-1426.
    >> Share

    April 2023
  171. HILDE K, Gudmundsdottir HK, Bains KES, Carlsen KCL, et al
    Third trimester fetal lung volume, thoracic circumference, and early infant lung function.
    Pediatr Pulmonol. 2023 Apr 26. doi: 10.1002/ppul.26431.
    >> Share

  172. KOUSSA S, Dombkowski A, Cukovic D, Poulik J, et al
    MicroRNA dysregulation in the heart and lung of infants with bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2023 Apr 26. doi: 10.1002/ppul.26422.
    >> Share

  173. ADLER-HALTOVSKY T, Gileles-Hillel A, Erlichman I, Eventov-Friedman S, et al
    Changes in ventilation modes in the last decade and their impact on the prevalence of bronchopulmonary dysplasia in preterm infants.
    Pediatr Pulmonol. 2023 Apr 21. doi: 10.1002/ppul.26418.
    >> Share

  174. GUPTA D, Greenberg RG, Natarajan G, Jani S, et al
    Association of patent ductus arteriosus with extubation failure among preterm infants.
    Pediatr Pulmonol. 2023 Apr 21. doi: 10.1002/ppul.26420.
    >> Share

  175. PRAPROTNIK M, Stucin Gantar I, Krivec U, Lucovnik M, et al
    Physical fitness trajectories from childhood to adolescence in extremely preterm children: A longitudinal cohort study.
    Pediatr Pulmonol. 2023 Apr 10. doi: 10.1002/ppul.26410.
    >> Share

  176. GHELAB Z, Bokov P, Teissier N, Micaelli D, et al
    Decannulation in congenital central hypoventilation syndrome.
    Pediatr Pulmonol. 2023 Apr 4. doi: 10.1002/ppul.26399.
    >> Share

  177. EASTWOOD-SUTHERLAND C, Lim K, Gale TJ, Wheeler KI, et al
    Detection of respiratory activity in newborn infants using a noncontact vision-based monitor.
    Pediatr Pulmonol. 2023 Apr 4. doi: 10.1002/ppul.26397.
    >> Share

  178. GOUSSARD P, van der Westhuizen S, Venkatakrishna S, Andronikou S, et al
    Foregut duplication cyst presenting at birth with airway compression.
    Pediatr Pulmonol. 2023 Apr 4. doi: 10.1002/ppul.26398.
    >> Share

  179. WYNTER Z, Pham Q, Mundy C, Walters C, et al
    Acquired lobar emphysema: A complication of severe bronchopulmonary dysplasia needing lobectomy.
    Pediatr Pulmonol. 2023 Apr 4. doi: 10.1002/ppul.26402.
    >> Share

  180. SMITH MA, Steurer MA, Mahendra M, Zinter MS, et al
    Sociodemographic factors associated with tracheostomy and mortality in bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2023;58:1237-1246.
    >> Share

  181. NAYIR BUYUKSAHIN H, Dogru D, Emiralioglu N, Ademhan Tural D, et al
    A case-control study of the effects of Aspergillus clinical phenotypes on pulmonary functions in patients with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:1185-1193.
    >> Share

  182. TOSCO A, Carnovale V, Claut L, Fabrizzi B, et al
    Clinical outcome of individuals carrying 5T;TG12 in trans with CFTR variants with varying clinical consequences.
    Pediatr Pulmonol. 2023;58:1253-1255.
    >> Share

  183. MCCOY KS, Blind J, Johnson T, Olson P, et al
    Clinical change 2 years from start of elexacaftor-tezacaftor-ivacaftor in severe cystic fibrosis.
    Pediatr Pulmonol. 2023;58:1178-1184.
    >> Share

  184. WANG A, Armstrong DS, Nixon GM
    High rates of procedure-related pain and anxiety in children with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:1247-1249.
    >> Share

  185. CLARKE E, Moore F, Gallagher A, Thomson S, et al
    The impact of CFTR modulators on bone health.
    Pediatr Pulmonol. 2023;58:1256.
    >> Share

  186. PASLEY K, Krivchenia K, Dell ML, McCoy KS, et al
    Clinical management of pediatric patients with cystic fibrosis and autism spectrum disorder.
    Pediatr Pulmonol. 2023;58:1160-1168.
    >> Share

  187. ZOBELL JT, Moss J, Creelman J, Christensen R, et al
    Implementation of a comprehensive pharmacy-driven immunization care process model in a pediatric cystic fibrosis clinic.
    Pediatr Pulmonol. 2023;58:1145-1151.
    >> Share

  188. RIGGSBEE D, Engdahl S, Pettit RS
    Evaluation of the safety of piperacillin-tazobactam extended infusion in pediatric cystic fibrosis patients.
    Pediatr Pulmonol. 2023;58:1092-1099.
    >> Share

  189. CHADWICK C, Arcinas R, Ham M, Huang R, et al
    The use of DXA for early detection of pediatric cystic fibrosis-related bone disease.
    Pediatr Pulmonol. 2023;58:1136-1144.
    >> Share

  190. SALINAS DB, Ginsburg DK, Wee CP, Saeed MM, et al
    Gradual increase in sweat chloride concentration is associated with a higher risk of CRMS/CFSPID to CF reclassification.
    Pediatr Pulmonol. 2023;58:1074-1084.
    >> Share

    March 2023
  191. BALAJTHY A, Balazs G, Kovacs T, Belteki G, et al
    Synchronized intermittent mandatory ventilation with volume guarantee and pressure support in neonates: Detailed analysis of ventilator parameters.
    Pediatr Pulmonol. 2023 Mar 17. doi: 10.1002/ppul.26384.
    >> Share

  192. BO B, Pugnaloni F, Licari A, Patel N, et al
    Ductus arteriosus flow predicts outcome in neonates with congecsion.
    Pediatr Pulmonol. 2023 Mar 15. doi: 10.1002/ppul.26385.
    >> Share

  193. MCKINNEY RL, Agarwal A
    Transition from intensive care unit to a portable ventilator in children with severe bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2023;58:712-719.
    >> Share

  194. SAKON C, Vogt H, Brown CD, Tillman EM, et al
    A survey assessing the impact of COVID-19 and elexacaftor/tezacaftor/ifavacaftor on both physical and mental health in adults with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:662-664.
    >> Share

  195. GONZALEZ-ROSALES N, Kasi AS, McCracken CE, Silva GL, et al
    Impact of viral respiratory infections on pulmonary exacerbations in children with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:871-877.
    >> Share

  196. SATHE M, Moshiree B, Aliaj E, Lee M, et al
    Need to study simplification of gastrointestinal medication regimen in cystic fibrosis in the era of highly effective modulators.
    Pediatr Pulmonol. 2023;58:811-818.
    >> Share

  197. SHEIKH S, Britt RD Jr, Ryan-Wenger NA, Khan AQ, et al
    Impact of elexacaftor-tezacaftor-ivacaftor on bacterial colonization and inflammatory responses in cystic fibrosis.
    Pediatr Pulmonol. 2023;58:825-833.
    >> Share

  198. SRIVATSA B, Srivatsa KR, Clark RH
    Assessment of validity and utility of a bronchopulmonary dysplasia outcome estimator.
    Pediatr Pulmonol. 2023;58:788-793.
    >> Share

  199. LOPES J, Vidal-Folch N, Lundquist P, Schimmenti LA, et al
    Aminoglycoside induced ototoxicity risk in the cystic fibrosis population: The utility of large-scale screening.
    Pediatr Pulmonol. 2023;58:819-824.
    >> Share

  200. SAVANT AP, McColley SA
    Cystic fibrosis year in review 2019: Section 3 multisystem-based care and research.
    Pediatr Pulmonol. 2023;58:697-703.
    >> Share

  201. SAVANT AP, McColley SA
    Cystic fibrosis year in review 2019: Section 2 pulmonary disease and infections.
    Pediatr Pulmonol. 2023;58:672-682.
    >> Share

    February 2023
  202. ROSE P, Rana S, Abbey C, Deskins S, et al
    Congenital Lobar Emphysema: A rare cause of respiratory failure in neonates.
    Pediatr Pulmonol. 2023 Feb 28. doi: 10.1002/ppul.26376.
    >> Share

  203. MONTERO GATO J, Sacristan PA, Vazquez NL, Martin MLH, et al
    Incidence of ultrasonographic signs of pneumothorax in asymptomatic neonates.
    Pediatr Pulmonol. 2023 Feb 27. doi: 10.1002/ppul.26378.
    >> Share

  204. STICKNEY CA, Levy PT, Abecassis L, Levin JC, et al
    Beyond the NICU: Comprehensive management of infants with bronchopulmonary dysplasia in the PICU.
    Pediatr Pulmonol. 2023 Feb 24. doi: 10.1002/ppul.26364.
    >> Share

  205. GATT D, Lapidus-Krol E, Chiu PPL
    The Long-Term Outcomes of Symptomatic Congenital Lobar Emphysema Patients.
    Pediatr Pulmonol. 2023 Feb 23. doi: 10.1002/ppul.26354.
    >> Share

  206. DREYFUS L, Butin M, Plaisant F, Claris O, et al
    Respiratory physiology during NAVA ventilation in neonates born with a congenital diaphragmatic hernia: the "NAVA-diaph" pilot study.
    Pediatr Pulmonol. 2023 Feb 17. doi: 10.1002/ppul.26357.
    >> Share

  207. CARR K, Wang H, Bedoya M
    Type I pleuropulmonary blastoma incidentally diagnosed in an infant with RSV bronchiolitis.
    Pediatr Pulmonol. 2023 Feb 17. doi: 10.1002/ppul.26363.
    >> Share

  208. DANAN C, Tauzin M, Jung C, Carbonnier B, et al
    Instrumental dead space: a glass ceiling for extremely low birth weight preterm infants? A dead space washout bench study.
    Pediatr Pulmonol. 2023 Feb 13. doi: 10.1002/ppul.26353.
    >> Share

  209. ROEPER R, Blinder H, Hayawi L, Barrowman N, et al
    Physical activity levels, pulmonary function, and MRI in children born extremely preterm: a comparison between children with and without bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2023 Feb 7. doi: 10.1002/ppul.26351.
    >> Share

  210. MILES KG, Powell AW, Critser P, Hardie W, et al
    Long-term exercise and pulmonary function outcomes in a contemporary cohort of children with congenital diaphragmatic hernia.
    Pediatr Pulmonol. 2023 Feb 7. doi: 10.1002/ppul.26348.
    >> Share

  211. STIBOY E, Chan M, Islam MS, Saravanos GL, et al
    Variation in clinical practice guidelines for use of palivizumab in preventing severe respiratory syncytial viral (RSV) disease in high-risk infants.
    Pediatr Pulmonol. 2023 Feb 7. doi: 10.1002/ppul.26324.
    >> Share

  212. ZANNIN E, Stoecklin B, Choi JY, Simpson SJ, et al
    Ventilatory response and stability of oxygen saturation during a hypoxic challenge in very preterm infants.
    Pediatr Pulmonol. 2023 Feb 7. doi: 10.1002/ppul.26343.
    >> Share

  213. GUR M, Bar-Yoseph R, Hanna M, Abboud D, et al
    Effect of Trikafta on bone density, body composition and exercise capacity in CF: A pilot study.
    Pediatr Pulmonol. 2023;58:577-584.
    >> Share

  214. SANTHANAM P, Egberg M, Kappelman MD
    Higher mortality rates associated with Clostridioides difficile infection in hospitalized children with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:484-491.
    >> Share

  215. SU Y, Tang Y, Tang X, Shen Y, et al
    Case report of a pediatric Chinese cystic fibrosis patient with the c.1521_1523delCTT/c.3874-4522A>G genotype.
    Pediatr Pulmonol. 2023;58:556-558.
    >> Share

  216. INCE HY, Phan H, Nasr SZ, Pierce JM, et al
    Clearing up the smoke: Physical and mental health considerations regarding cannabis use in adolescents with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:398-407.
    >> Share

  217. BUSTAMANTE AE, Fernandez LT, Rivas LC, Mercado-Longoria R, et al
    Cystic fibrosis-related mortality trends in Mexico between 1999 and 2020.
    Pediatr Pulmonol. 2023;58:632-634.
    >> Share

  218. AOYAMA BC, McGrath-Morrow SA, Collaco JM
    Socioeconomic status and outpatient follow-up in children with bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2023;58:623-626.
    >> Share

  219. TURKER E, Sener S, Guzelkas I, Emiralioglu N, et al
    Immunoglobulin A vasculitis in a child: Secondary to COVID-19 or cystic fibrosis?
    Pediatr Pulmonol. 2023;58:627-628.
    >> Share

  220. ORUM MB, Ronsholt FF, Jeppesen M, Bendstrup E, et al
    Outcome of elexacaftor/tezacaftor/ivacaftor therapy in patients with cystic fibrosis and solid organ transplantation.
    Pediatr Pulmonol. 2023;58:602-605.
    >> Share

  221. GILELES-HILLEL A, Yochi Harpaz L, Breuer O, Reiter J, et al
    The clinical yield of bronchoscopy in the management of cystic fibrosis: A retrospective multicenter study.
    Pediatr Pulmonol. 2023;58:500-506.
    >> Share

  222. BOAT T, Hente E, Hardie W, Szczesniak R, et al
    Body composition and functional correlates of CF youth experiencing pulmonary exacerbation and recovery.
    Pediatr Pulmonol. 2023;58:457-464.
    >> Share

    January 2023
  223. WEI YJ, Ju YT, Hsieh ML, Kan CD, et al
    Surgical ligation, not transcatheter closure, associated with a higher severity of bronchopulmonary dysplasia in extremely preterm infant intervened for patent ductus arteriosus.
    Pediatr Pulmonol. 2023 Jan 25. doi: 10.1002/ppul.26325.
    >> Share

  224. ONG T, Bell S, Britto MT, Gamel B, et al
    Transforming the Nutrition Care Model for Infants with Cystic Fibrosis: a qualitative study of clinicians' perspectives.
    Pediatr Pulmonol. 2023 Jan 25. doi: 10.1002/ppul.26330.
    >> Share

  225. WANG J, Zhang A, Huang F, Xu J, et al
    MSC EXO and tempol ameliorate bronchopulmonary dysplasia in newborn rats by activating HIF-1alpha.
    Pediatr Pulmonol. 2023 Jan 17. doi: 10.1002/ppul.26317.
    >> Share

  226. WANG PY, Tseng WC, Wu ET, Lu FL, et al
    The Implications of Airway Anomalies on Children with Congenital Heart Disease and Bronchiolitis.
    Pediatr Pulmonol. 2023 Jan 17. doi: 10.1002/ppul.26320.
    >> Share

  227. SHANTAGIRI A, Prabhakar N, Bhatia A, Roy S, et al
    CONGENITAL LUNG MALFORMATIONS- SPOT ONE, HUNT FOR OTHERS.
    Pediatr Pulmonol. 2023 Jan 12. doi: 10.1002/ppul.26316.
    >> Share

  228. SATO S, Yamazaki S, Suzuki K, Kudo T, et al
    Cryptogenic organizing pneumonia in an infant.
    Pediatr Pulmonol. 2023 Jan 11. doi: 10.1002/ppul.26313.
    >> Share

  229. FRAUCHIGER BS, Ramsey KA, Usemann J, Kieninger E, et al
    Variability of clinically measured lung clearance index in children with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:197-205.
    >> Share

  230. MITCHELL B, Kormelink L, Kuhn R, Schadler A, et al
    Retrospective review of vancomycin monitoring via trough only versus two-point estimated area under the curve in pediatric and adult patients with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:239-245.
    >> Share

  231. ILGIN SISMAN H, Peker S, Gokdemir Y, Erdem Eralp E, et al
    Parent's report on oral health-related quality of life of children with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:246-252.
    >> Share

  232. FLYNN H, Wright B, Larson Ode K
    Assessing the occurrence of reproductive health counseling in adolescents with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:332-335.
    >> Share

  233. ZAMPOLI M, Verstraete J, Nguyen-Khoa T, Sermet-Gaudelus I, et al
    beta-adrenergic sweat test in children with inconclusive cystic fibrosis diagnosis: Do we need new reference ranges?
    Pediatr Pulmonol. 2023;58:187-196.
    >> Share

  234. NAYIR BUYUKSAHIN H, Emiralioglu N, Ademhan Tural D, Ozsezen B, et al
    Coexistence of cystic fibrosis with other genetic disorders: A case series.
    Pediatr Pulmonol. 2023;58:345-347.
    >> Share

  235. SHORT C, Abkir M, Pinnell S, Proctor O, et al
    Migration is not the perfect answer: How the cross-talk error correction for multiple breath nitrogen washout (MBWN(2) ) parameters differs on directly collected vs. legacy data.
    Pediatr Pulmonol. 2023;58:328-331.
    >> Share

  236. CHO Y, Kwon Y, Ruth C, Cheng S, et al
    The burden of sleep disordered breathing in infants with Down syndrome referred to tertiary sleep center.
    Pediatr Pulmonol. 2023 Jan 1. doi: 10.1002/ppul.26302.
    >> Share

    December 2022
  237. MARCZAK H, Chrusciel J, Kulus M, Krenke K, et al
    COVID-19 in patients with persistent tachypnea of infancy.
    Pediatr Pulmonol. 2022 Dec 20. doi: 10.1002/ppul.26281.
    >> Share

  238. HORNE RS
    The natural history of obstructive sleep apnea in infancy.
    Pediatr Pulmonol. 2022 Dec 14. doi: 10.1002/ppul.26280.
    >> Share

  239. YEE AK, Siriwardhana LS, Nixon GM, Walter LM, et al
    Periodic breathing in clinically stable very preterm infants.
    Pediatr Pulmonol. 2022 Dec 12. doi: 10.1002/ppul.26273.
    >> Share

  240. REHANI MR, Marcus MS, Harris AB, Farrell PM, et al
    Variation in cystic fibrosis newborn screening algorithms in the United States.
    Pediatr Pulmonol. 2022 Dec 11. doi: 10.1002/ppul.26279.
    >> Share

  241. POLETTO S, Trevisanuto D, Ramaswamy VV, Seni AHA, et al
    Bubble CPAP respiratory support devices for infants in low-resource settings.
    Pediatr Pulmonol. 2022 Dec 9. doi: 10.1002/ppul.26258.
    >> Share

  242. DAVIS J, Ryan M, Marchetti P, Dahlberg SE, et al
    Real-world feasibility of short-term, unsupervised home spirometry in CF.
    Pediatr Pulmonol. 2022;57:3129-3135.
    >> Share

  243. SAHOO N, Dhochak N, Jat KR, Sankar J, et al
    Development of algorithm for diagnosis of cystic fibrosis in absence of sweat chloride testing in resource-limited setting.
    Pediatr Pulmonol. 2022;57:3077-3083.
    >> Share

  244. HATZIAGOROU E, Avramidou V, Gioulvanidou M, Talimtzi P, et al
    Pulmonary exacerbations, airway pathogens, and long-term course of lung clearance index in children and young adults with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:3069-3076.
    >> Share

  245. JENNINGS D, List R, Bruschwein H, Compton M, et al
    Social determinants of health screening and intervention: A cystic fibrosis quality improvement process.
    Pediatr Pulmonol. 2022;57:3035-3043.
    >> Share

  246. HATZIAGOROU E, Manika K, Kyrvasili SS, Kotoulas SC, et al
    Pulmonary medication adherence among children and adults with cystic fibrosis: Is there an association with disease severity?
    Pediatr Pulmonol. 2022;57:3017-3026.
    >> Share

  247. CORNET M, Robin G, Ciciriello F, Bihouee T, et al
    Profiling the response to lumacaftor-ivacaftor in children with cystic between fibrosis and new insight from a French-Italian real-life cohort.
    Pediatr Pulmonol. 2022;57:2992-2999.
    >> Share

  248. SUNMAN B, Yalcin E, Ozsezen B, Tural DA, et al
    Association between early chronic methicillin-susceptible Staphylococcus aureus colonization and lung function in children with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:2963-2970.
    >> Share

  249. LYMAN BC, Seay J, Contreary C, Savant AP, et al
    Elexacaftor-tezacaftor-ivacaftor overdose in an adolescent female with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:3174-3176.
    >> Share

    November 2022
  250. GAPP S, Garbade SF, Feyh P, Brockow I, et al
    German Newborn Screening for Cystic Fibrosis - Parental perspectives and suggestions for improvements.
    Pediatr Pulmonol. 2022 Nov 29. doi: 10.1002/ppul.26263.
    >> Share

  251. KUKKOLA HL, Kirjavainen T
    Obstructive sleep apnea in young infants: Sleep position dependence and spontaneous improvement.
    Pediatr Pulmonol. 2022 Nov 27. doi: 10.1002/ppul.26255.
    >> Share

  252. ZANNIN E, Rigotti C, Neumann RP, Dellaca RL, et al
    Oscillatory mechanics in very preterm infants on continuous positive airway pressure support: reference values.
    Pediatr Pulmonol. 2022 Nov 23. doi: 10.1002/ppul.26247.
    >> Share

  253. MISHRA A, Joshi A, Londhe A, Deshmukh L, et al
    Surfactant Administration in Preterm babies (28-36 weeks) with Respiratory Distress Syndrome: LISA vs InSurE, an Open-Label Randomized Controlled Trial.
    Pediatr Pulmonol. 2022 Nov 23. doi: 10.1002/ppul.26246.
    >> Share

  254. ROCK MJ, Baker M, Antos N, Farrell PM, et al
    REFINEMENT OF NEWBORN SCREENING FOR CYSTIC FIBROSIS WITH NEXT GENERATION SEQUENCING.
    Pediatr Pulmonol. 2022 Nov 23. doi: 10.1002/ppul.26253.
    >> Share

  255. AKANGIRE G, Lachica C, Noel-MacDonnell J, Begley A, et al
    Outcomes of Infants with Severe Bronchopulmonary Dysplasia Who Received Tracheostomy and Home Ventilation.
    Pediatr Pulmonol. 2022 Nov 14. doi: 10.1002/ppul.26248.
    >> Share

  256. WANG K, Zhou X, Gao S, Li F, et al
    Non-invasive high-frequency oscillatory ventilation vs nasal intermittent positive pressure ventilation for preterm infants as an extubation support: a systematic review and meta-analysis.
    Pediatr Pulmonol. 2022 Nov 13. doi: 10.1002/ppul.26244.
    >> Share

  257. CAI LM, Yao Y, Jiao AX, Zhang FZ, et al
    Circumferential subglottic hemangioma misdiagnosed twice in an infant with life-threatening dyspnea.
    Pediatr Pulmonol. 2022 Nov 9. doi: 10.1002/ppul.26228.
    >> Share

  258. GOTH FEM, Green K, Hansen BM, Agertoft L, et al
    From neonatal lung function to lung function and respiratory morbidity at 6-year follow-up.
    Pediatr Pulmonol. 2022 Nov 8. doi: 10.1002/ppul.26240.
    >> Share

  259. CAVIGIOLI F, Bresesti I, Di Peri A, Cerritelli F, et al
    Tidal volume optimization and heart rate response during stabilization of very preterm infants.
    Pediatr Pulmonol. 2022 Nov 2. doi: 10.1002/ppul.26229.
    >> Share

  260. MOHSEN N, Nasef N, Ghanem M, Yeung T, et al
    Accuracy of lung and diaphragm ultrasound in predicting successful extubation in extremely preterm infants: A prospective observational study.
    Pediatr Pulmonol. 2022 Nov 2. doi: 10.1002/ppul.26223.
    >> Share

  261. OZSIN-OZLER C, Duruel O, Pinar A, Ozbek B, et al
    Dental caries and associated salivary biomarkers in patients with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:2839-2846.
    >> Share

  262. DACCO V, Sciarrabba CS, Corti F, Rosazza C, et al
    A successful treatment of a lobar atelectasis in a patient with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:2868-2871.
    >> Share

  263. GILELES-HILLEL A, Soesman LH, Miari S, Breuer O, et al
    The utility of glucose area under the curve from the oral glucose tolerance test as a screening tool for cystic fibrosis-related diabetes.
    Pediatr Pulmonol. 2022;57:2774-2780.
    >> Share

  264. FRIEDMAN D, Smith BA, Bruce A, Schwartz CE, et al
    Feasibility and acceptability of a CF-specific cognitive-behavioral preventive intervention for adults integrated into team-based care.
    Pediatr Pulmonol. 2022;57:2781-2790.
    >> Share

  265. KASS AP, Berbert L, Dahlberg S, Bern E, et al
    Eating disorders in adolescents and young adults with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:2791-2797.
    >> Share

  266. GUIMBELLOT JS, Ryan KJ, Anderson JD, Parker KL, et al
    Plasma and cellular ivacaftor concentrations in patients with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:2745-2753.
    >> Share

  267. GRAZIANO S, Boldrini F, Quittner AL, Fiocchi AG, et al
    Stress and mental health in adolescents and young adults with cystic fibrosis 1 year after the COVID pandemic: Findings from an Italian sample.
    Pediatr Pulmonol. 2022;57:2707-2714.
    >> Share

  268. CAUSER AJ, Shute JK, Cummings MH, Shepherd AI, et al
    Elexacaftor-Tezacaftor-Ivacaftor improves exercise capacity in adolescents with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:2652-2658.
    >> Share

  269. LINDLEY B, Bhakta Z, Gray K, Watanabe A, et al
    Pharmacokinetics of intermittent dosed intravenous vancomycin in adult persons with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:2646-2651.
    >> Share

  270. SULEYMAN A, Tamay Z, Guler N
    Antibiotic allergy in children with cystic fibrosis: A retrospective case-control study.
    Pediatr Pulmonol. 2022;57:2622-2628.
    >> Share

  271. RAMASLI GURSOY T, Sismanlar Eyuboglu T, Aslan AT, Emiralioglu N, et al
    Psychological status of mothers of children with cystic fibrosis and primary ciliary dyskinesia.
    Pediatr Pulmonol. 2022;57:2665-2673.
    >> Share

  272. REEVES PT, Bennett WC, McCown MY, Welsh SK, et al
    The Cystic Fibrosis Action Plan: A low health literacy, pictographic self-management tool with clinical automation.
    Pediatr Pulmonol. 2022;57:2847-2850.
    >> Share

    October 2022
  273. DAWSON SK, D'Andrea LA, Lagatta JM
    Management of diuretics in infants with bronchopulmonary dysplasia discharged on home oxygen.
    Pediatr Pulmonol. 2022 Oct 31. doi: 10.1002/ppul.26221.
    >> Share

  274. YANG W, Gao Y, Li P, Eckman MH, et al
    Should asymptomatic patients with congenital lung malformations undergo surgery? A decision analysis.
    Pediatr Pulmonol. 2022 Oct 17. doi: 10.1002/ppul.26206.
    >> Share

  275. MCGARRY ME, Ren CL, Wu R, Farrell PM, et al
    Detection of Disease-Causing CFTR Variants In State Newborn Screening Programs.
    Pediatr Pulmonol. 2022 Oct 13. doi: 10.1002/ppul.26209.
    >> Share

  276. SCHROEDER L, Kuelshammer M, Dolscheid-Pommerich R, Holdenrieder S, et al
    NT-proBNP and Zlog-transformed NT-proBNP values predict extubation failure in critically ill neonates with pulmonary hypertension and ventricular dysfunction.
    Pediatr Pulmonol. 2022 Oct 10. doi: 10.1002/ppul.26193.
    >> Share

  277. DEL PUPPO M, Meister L, Medale M, Allary C, et al
    Heliox simulations for initial management of congenital laryngotracheal stenosis.
    Pediatr Pulmonol. 2022 Oct 8. doi: 10.1002/ppul.26189.
    >> Share

  278. ALMUDARES F, Hagan J, Chen X, Devaraj S, et al
    Growth and differentiation factor 15 (GDF15) levels predict adverse respiratory outcomes in premature neonates.
    Pediatr Pulmonol. 2022 Oct 7. doi: 10.1002/ppul.26197.
    >> Share

  279. DOMINGO-ALEMAN P, Samperiz-Sinovas L, Martinez-Tourne A, Puertas-Martinez AI, et al
    Early-onset neonatal round pneumonia.
    Pediatr Pulmonol. 2022 Oct 6. doi: 10.1002/ppul.26192.
    >> Share

  280. JONSSON B, Drevhammar T, Donaldsson S
    Function of neonatal CPAP systems and the importance of total flow.
    Pediatr Pulmonol. 2022 Oct 5. doi: 10.1002/ppul.26195.
    >> Share

  281. ESCUDERO-AVILA R, Pecellin CD, Valera MJM, Hernandez LC, et al
    False negatives in the newborn screening for Cystic Fibrosis in Western Andalusia: Results from a 10- year experience.
    Pediatr Pulmonol. 2022 Oct 4. doi: 10.1002/ppul.26183.
    >> Share

  282. GOUSSARD P, Schubert P, Janson J, Naidoo S, et al
    "To the Editor" Recurrent wheezing caused by the combination of Bronchogenic Cyst and Congenital Lobar Emphysema in a young infant.
    Pediatr Pulmonol. 2022 Oct 4. doi: 10.1002/ppul.26181.
    >> Share

  283. WILSON LM, Potter A, Maher C, Ellis MJ, et al
    Feasibility of the A-STEP for the assessment of exercise capacity in people with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:2524-2532.
    >> Share

  284. SHANTHIKUMAR S, Ranganathan S, Neeland MR
    Ivacaftor, not ivacaftor/lumacaftor, associated with lower pulmonary inflammation in preschool cystic fibrosis.
    Pediatr Pulmonol. 2022;57:2549-2552.
    >> Share

  285. NASR SZ, Gokdemir Y, Erdem E, Karakoc F, et al
    Collaboration between two CF centers; one in USA and one in Turkey before and during CoV2 pandemic.
    Pediatr Pulmonol. 2022;57:2553-2557.
    >> Share

  286. HUANG L, Lai HJ, Antos N, Rock MJ, et al
    Defining and identifying early-onset lung disease in cystic fibrosis with cumulative clinical characteristics.
    Pediatr Pulmonol. 2022;57:2363-2373.
    >> Share

  287. GUR M, Zuckerman-Levin N, Masarweh K, Hanna M, et al
    The effect of probiotic administration on metabolomics and glucose metabolism in CF patients.
    Pediatr Pulmonol. 2022;57:2335-2343.
    >> Share

  288. CHUNG J, Iyengar A, Santry L, Swanson E, et al
    Changes in respiratory management and the impact on bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2022;57:2327-2334.
    >> Share

  289. HAMOUDA S, Hadj Fredj S, Messaoud T, Scotet V, et al
    Up-to-date incidence and initial characteristics of cystic fibrosis in Tunisia.
    Pediatr Pulmonol. 2022;57:2540-2541.
    >> Share

    September 2022
  290. MARCZAK H, Peradzynska J, Lange J, Boguslawski S, et al
    Pulmonary function in children with persistent tachypnea of infancy.
    Pediatr Pulmonol. 2022 Sep 29. doi: 10.1002/ppul.26162.
    >> Share

  291. YONEDA K, Amari S, Mikami M, Uchida K, et al
    Development of Mortality Prediction Models for Infants with Isolated, Left-Sided Congenital Diaphragmatic Hernia Before and After Birth.
    Pediatr Pulmonol. 2022 Sep 29. doi: 10.1002/ppul.26172.
    >> Share

  292. KASNIYA G, Weinberger B, Cerise J, Pulju M, et al
    Lung Ultrasound Assessment of Pulmonary Edema in Neonates with Chronic Lung Disease Before and After Diuretic Therapy.
    Pediatr Pulmonol. 2022 Sep 29. doi: 10.1002/ppul.26150.
    >> Share

  293. MA HR, Deng BY, Liu J, Jiang P, et al
    Lung Ultrasound to Diagnose Infectious Pneumonia of Newborns: A Prospective Multicenter Study.
    Pediatr Pulmonol. 2022 Sep 28. doi: 10.1002/ppul.26168.
    >> Share

  294. LI L, Liu R, Wang Y, Wang W, et al
    Type II Congenital Pulmonary Airway Malformation with Primary Ciliary Dyskinesia in a 4-year-old Child: A Case Report.
    Pediatr Pulmonol. 2022 Sep 27. doi: 10.1002/ppul.26167.
    >> Share

  295. DANAN C, Tauzin M, Jung C, Durrmeyer X, et al
    Humidity during high-frequency oscillatory ventilation compared to intermittent positive pressure ventilation in extremely preterm neonates: An in vitro and in vivo observational study.
    Pediatr Pulmonol. 2022 Sep 14. doi: 10.1002/ppul.26157.
    >> Share

  296. HARRIS C, Morris S, Lunt A, Peacock J, et al
    Influence of bronchopulmonary dysplasia on lung function in adolescents who were born extremely prematurely.
    Pediatr Pulmonol. 2022 Sep 13. doi: 10.1002/ppul.26151.
    >> Share

  297. JANA T, Vaclav K, Daniela M, Petr K, et al
    Symptomatic preterm infants suffer from lung function deficits, regardless of bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2022 Sep 13. doi: 10.1002/ppul.26144.
    >> Share

  298. GUDMUNDSDOTTIR HK, Hilde K, Bains KES, Fardig M, et al
    Online supplement for the article: Fetal thoracic circumference in mid-pregnancy and infant lung function.
    Pediatr Pulmonol. 2022 Sep 13. doi: 10.1002/ppul.26153.
    >> Share

  299. HAIDER S, Azhar N, Zahid M, Iqbal K, et al
    Comparative effectiveness of Calfactant and Beractant in Neonatal Respiratory Distress Syndrome: A systemic review and meta-analysis.
    Pediatr Pulmonol. 2022 Sep 12. doi: 10.1002/ppul.26149.
    >> Share

  300. DIGGIKAR S, Paul A, Razak A, Chandrasekaran M, et al
    Respiratory Infections in Children Born Preterm in Low and Middle-income countries - A Systematic Review.
    Pediatr Pulmonol. 2022 Sep 7. doi: 10.1002/ppul.26128.
    >> Share

  301. GIACALONE VD, Moncada-Giraldo D, Margaroli C, Brown MR, et al
    Pilot study of inflammatory biomarkers in matched induced sputum and bronchoalveolar lavage of 2-year-olds with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:2189-2198.
    >> Share

  302. JANUSKA MN, Langfelder-Schwind E, Berdella MN
    Overcoming health disparities in access to CFTR modulator therapies: One child's journey with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:2273-2275.
    >> Share

  303. SALVATORE D, Cimino G, Troiani P, Bignamini E, et al
    Elexacaftor/tezacaftor/ivacaftor in children aged 6-11 years with cystic fibrosis, at least one F508DEL allele, and advanced lung disease: A 24-week observational study.
    Pediatr Pulmonol. 2022;57:2253-2256.
    >> Share

  304. STEINDOR M, Wagner CE, Kavvalou A, Bock C, et al
    Indications and outcome of home high-flow nasal therapy in children, a single-center experience.
    Pediatr Pulmonol. 2022;57:2048-2052.
    >> Share

  305. GIARDINA M, Barilla D, Crimi C, Arone A, et al
    Ultrasound-guided placement of long peripheral cannula in children with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:2060-2066.
    >> Share

  306. BANWELL E, Collaco JM, Oates GR, Rice JL, et al
    Area deprivation and respiratory morbidities in children with bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2022;57:2053-2059.
    >> Share

    August 2022
  307. SOLIS-GARCIA G, Gonzalez-Pacheco N, Ramos-Navarro C, Vigil-Vazquez S, et al
    Lung recruitment in neonatal high-frequency oscillatory ventilation with volume-guarantee.
    Pediatr Pulmonol. 2022 Aug 22. doi: 10.1002/ppul.26124.
    >> Share

  308. ELDERS BBLJ, Tiddens HAWM, Pijnenburg MWH, Reiss IKM, et al
    Lung structure and function on MRI in preterm born school children with and without BPD: a feasibility study.
    Pediatr Pulmonol. 2022 Aug 18. doi: 10.1002/ppul.26119.
    >> Share

  309. OZAWA Y, Miyake F, Isayama T
    Efficacy and safety of permissive hypercapnia in preterm infants: A systematic review.
    Pediatr Pulmonol. 2022 Aug 9. doi: 10.1002/ppul.26108.
    >> Share

  310. NING J
    A new oxygen therapy support device for infant bronchoscopy?
    Pediatr Pulmonol. 2022 Aug 6. doi: 10.1002/ppul.26105.
    >> Share

  311. KITAJIMA H, Fujimura M, Takeuchi M, Kawamoto Y, et al
    Intrauterine Ureaplasma is associated with small airway obstruction in extremely preterm infants.
    Pediatr Pulmonol. 2022 Aug 5. doi: 10.1002/ppul.26098.
    >> Share

  312. NASCIMENTO MS, do Prado C, Costa ELV, Alcala GC, et al
    Effect of Flow rate on the end-expiratory lung volume in infants with bronchiolitis using high-flow nasal cannula evaluated through electrical impedance tomography.
    Pediatr Pulmonol. 2022 Aug 5. doi: 10.1002/ppul.26082.
    >> Share

  313. REITER J, Breuer O, Cohen-Cymberknoh M, Forno E, et al
    Sleep in children with cystic fibrosis: More under the covers.
    Pediatr Pulmonol. 2022;57:1944-1951.
    >> Share

    July 2022
  314. ONG JWY, Everitt L, Hiscutt J, Griffiths C, et al
    Characteristics and outcome of infants with bronchopulmonary dysplasia established on long-term ventilation from neonatal intensive care.
    Pediatr Pulmonol. 2022 Jul 19. doi: 10.1002/ppul.26072.
    >> Share

  315. HOUSE M, Klein S, Parham D, Hysinger EB, et al
    Frequent hypoxemia found in infants with bronchopulmonary dysplasia after weaning home oxygen.
    Pediatr Pulmonol. 2022 Jul 13. doi: 10.1002/ppul.26076.
    >> Share

  316. REN CL, Slaven JE, Haas DM, Haneline LS, et al
    Forced Expiratory Flows and Diffusion Capacity in Infants Born from Mothers with Pre-eclampsia.
    Pediatr Pulmonol. 2022 Jul 7. doi: 10.1002/ppul.26064.
    >> Share

  317. BUENDIA JA, Patino DG, Lindarte EF
    Vitamin A supplementation for the prevention of chronic lung disease in premature infants: a cost-utility analysis.
    Pediatr Pulmonol. 2022 Jul 6. doi: 10.1002/ppul.26067.
    >> Share

  318. RODRIGUEZ-FANJUL J, Corsini I, Ortiz CS, Bobillo-Perez S, et al
    Lung ultrasound to evaluate lung recruitment in neonates with respiratory distress (RELUS study).
    Pediatr Pulmonol. 2022 Jul 6. doi: 10.1002/ppul.26066.
    >> Share

  319. GALVIS C, Colmenares A, Cabrales L, Ibata L, et al
    Impact of immunoprophylaxis with palivizumab on respiratory syncytial virus infection in preterm infants less than 35 weeks in Colombian hospitals.
    Pediatr Pulmonol. 2022 Jul 6. doi: 10.1002/ppul.26051.
    >> Share

  320. EGALA A, Hariharan R, Sarangarajan S, Puntambekar A, et al
    An uncommon cause of spontaneous pneumothorax in a febrile infant: Atypical Kawasaki Disease.
    Pediatr Pulmonol. 2022 Jul 5. doi: 10.1002/ppul.26062.
    >> Share

  321. DRISCOLL S, Carroll WD, Nichani S, Fishwick R, et al
    COVID-19 infection and nocardiosis causing the death of an adolescent with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:1823-1825.
    >> Share

  322. SAVANT AP
    Cystic fibrosis year in review 2021.
    Pediatr Pulmonol. 2022;57:1590-1599.
    >> Share

  323. THAVAMANI A, Umapathi KK, Kutney K, Sferra TJ, et al
    Cystic fibrosis-related liver disease is an independent risk factor for mortality and increased health care resource utilization in hospitalized pediatric patients with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:1717-1725.
    >> Share

  324. MCKINZIE CJ, Kam CW, Parry R, Darby M, et al
    Pharmacist-administered audiology screening for pediatric cystic fibrosis patients exposed to high-dose aminoglycosides: A pilot study.
    Pediatr Pulmonol. 2022;57:1814-1817.
    >> Share

  325. MOLLER R, Nielsen BU, Faurholt-Jepsen D, Katzenstein TL, et al
    Use of inhaled antibiotics among Danish patients with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:1726-1734.
    >> Share

  326. ALLAER L, Lejeune S, Mordacq C, Deschildre A, et al
    Primary ciliary dyskinesia and fungal infections: Two cases of allergic bronchopulmonary aspergillosis in children.
    Pediatr Pulmonol. 2022;57:1809-1813.
    >> Share

  327. COLLACO JM, Tracy MC, Sheils CA, Rice JL, et al
    Insurance coverage and respiratory morbidities in bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2022;57:1735-1743.
    >> Share

  328. BOUZEK DC, Ren CL, Thompson M, Slaven JE, et al
    Evaluating FEV1 decline in diagnosis and management of pulmonary exacerbations in children with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:1709-1716.
    >> Share

  329. MUIRHEAD C, Verzasconi D, Joshi S
    At-home compounding preparation of slow desensitization of elexacaftor/tezacaftor/ivacaftor for delayed hypersensitivity rash.
    Pediatr Pulmonol. 2022;57:1779-1781.
    >> Share

    June 2022
  330. AUER-HACKENBERG L, Stroicz P, Hofstatter E, Brandner J, et al
    Breath-dependent pressure fluctuations in various constant- and variable-flow neonatal CPAP devices.
    Pediatr Pulmonol. 2022 Jun 30. doi: 10.1002/ppul.26050.
    >> Share

  331. RAO P, Charki S, Aradhya AS, Diggikar S, et al
    Prediction score for prolonged hospital stay in Meconium aspiration syndrome: A Multicentric collaborative cohort of South India.
    Pediatr Pulmonol. 2022 Jun 27. doi: 10.1002/ppul.26044.
    >> Share

  332. RUB DM, Sivieri EM, Abbasi S, Sieberlich W, et al
    Comparison of Nasal Intermittent Positive Pressure Ventilation and Bubble CPAP with an In-Line High Frequency Interrupter in a Premature Infant Lung Model.
    Pediatr Pulmonol. 2022 Jun 20. doi: 10.1002/ppul.26039.
    >> Share

  333. KURUMA K, Otomo T, Sakama T, Akiyama K, et al
    Breath sound analyses of infants with respiratory syncytial virus acute bronchiolitis.
    Pediatr Pulmonol. 2022 Jun 7. doi: 10.1002/ppul.26034.
    >> Share

  334. ALESSANDRO P, Annamaria S, Letizia PM, Stefano N, et al
    Early lung ultrasound score to predict non-invasive ventilation needing in neonates from 33 weeks of gestational age: a multi-centric study.
    Pediatr Pulmonol. 2022 Jun 6. doi: 10.1002/ppul.26031.
    >> Share

  335. ENZER KG, Wine TM, Gien J, Somme S, et al
    Posterior tracheopexy for preterm infants with severe bronchopulmonary dysplasia and severe tracheobronchomalacia: A case series.
    Pediatr Pulmonol. 2022 Jun 4. doi: 10.1002/ppul.26029.
    >> Share

  336. ARMERO G, Penela-Sanchez D, Belmonte J, Gomez-Barroso D, et al
    Concentrations of nitrogen compounds are related to severe rhinovirus infection in infants. A time-series analysis from the reference area of a pediatric university hospital in Barcelona.
    Pediatr Pulmonol. 2022 Jun 2. doi: 10.1002/ppul.26021.
    >> Share

  337. ABDELMAWLA M, Seleem W, Farooqui M, Eltayeb A, et al
    Prediction of Weaning Readiness off Nasal CPAP in Preterm Infants Using Point-of-Care Lung Ultrasound.
    Pediatr Pulmonol. 2022 Jun 2. doi: 10.1002/ppul.26014.
    >> Share

  338. MELLOR X, Schindler T, Saab S, Roesch E, et al
    Eosinophilic esophagitis in cystic fibrosis: A case series with long-term follow-up.
    Pediatr Pulmonol. 2022;57:1557-1561.
    >> Share

  339. ISRAELI T, Eisenstadt I, Shoseyov D, Armoni S, et al
    Respiratory physiotherapy in patients with cystic fibrosis and upper limb deep vein thrombosis.
    Pediatr Pulmonol. 2022;57:1552-1554.
    >> Share

  340. XUEREB J, Sammut P, Vella C, Balfour-Lynn IM, et al
    Resolution of lobe collapse in a child with cystic fibrosis with Mycobacterium abscessus using serial intrabronchial rhDNase.
    Pediatr Pulmonol. 2022;57:1549-1551.
    >> Share

  341. YUAN Y, Yang Y, Lei X, Dong W, et al
    Caffeine and bronchopulmonary dysplasia: Clinical benefits and the mechanisms involved.
    Pediatr Pulmonol. 2022;57:1392-1400.
    >> Share

  342. WOJSYK-BANASZAK I, Wieckowska B, Stachowiak Z, Kycler M, et al
    Predictive value of impulse oscillometry and multiple breath washout parameters in pediatric patients with cystic fibrosis pulmonary exacerbation.
    Pediatr Pulmonol. 2022;57:1466-1474.
    >> Share

  343. MARPOLE R, Wilson AC
    Benefits of reviewing pancreatic function in children with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:1537-1539.
    >> Share

  344. MCKINZIE CJ, Hagood JS, Fiorino EK, Fishman MP, et al
    The role of pharmacy services beyond cystic fibrosis: A case for support in childhood interstitial lung disease.
    Pediatr Pulmonol. 2022;57:1535-1536.
    >> Share

  345. MELICOFF E, Ruiz FE, Hosek K, Mallory GB, et al
    Cystic fibrosis lung transplant recipients 10 years of age or younger: Predisposing factors for end-stage disease.
    Pediatr Pulmonol. 2022;57:1513-1519.
    >> Share

  346. SUNMAN B, Emiralioglu N, Hazirolan G, Sener B, et al
    Effectiveness of different eradication treatment protocols for new-onset Pseudomonas aeruginosa in children with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:1456-1465.
    >> Share


  347. V. YOUNG INVESTIGATOR'S ORAL COMMUNICATIONS.
    Pediatr Pulmonol. 2022;57 Suppl 2:S89-S93.
    >> Share

    May 2022
  348. COUSINS M, Hart K, Williams EM, Kotecha S, et al
    Impaired exercise outcomes with significant bronchodilator responsiveness in children with prematurity-associated obstructive lung disease.
    Pediatr Pulmonol. 2022 May 30. doi: 10.1002/ppul.26019.
    >> Share

  349. CORSINI I, Parri N, Ficial B, Ciarcia M, et al
    Lung ultrasound in Italian Neonatal Intensive Care Units: a national survey.
    Pediatr Pulmonol. 2022 May 30. doi: 10.1002/ppul.26025.
    >> Share

  350. EL-SHEIKH M, Elmahdy H, Nassar M, Fouda M, et al
    Role of Soluble Triggering Receptors Expressed on Myeloid Cells -1 and 25-hydroxy Vitamin D as Early Diagnostic Markers of Neonatal Ventilator-Associated Pneumonia: A Prospective Cohort Study.
    Pediatr Pulmonol. 2022 May 27. doi: 10.1002/ppul.26016.
    >> Share

  351. VERD S, Morey R, Ginovart G, Moliner E, et al
    Due emphasis on the role of human milk feeding to prevent neonatal respiratory morbidity.
    Pediatr Pulmonol. 2022 May 26. doi: 10.1002/ppul.26017.
    >> Share

  352. KUGELMAN A
    *Neonatal Pulmonology: "Year in Review" for the Pediatric Pulmonologist.
    Pediatr Pulmonol. 2022 May 20. doi: 10.1002/ppul.25960.
    >> Share

  353. SOONG WJ, Tsao PC, Yang CF, Sung YH, et al
    Early detection of laryngeal cleft in infants by novel technique of flexible endoscopy with sustained pharyngeal inflation.
    Pediatr Pulmonol. 2022 May 20. doi: 10.1002/ppul.25988.
    >> Share

  354. MIKHAEL M, Cleary JP, Zaniletti I, Truog WE, et al
    Chronic Lung Disease in Full-Term Infants: Characteristics and Neonatal Intensive Care Outcomes in Infants Referred to Children's Hospitals.
    Pediatr Pulmonol. 2022 May 16. doi: 10.1002/ppul.25983.
    >> Share

  355. LUCIA L, Correani A, Pasqualini M, Antognoli L, et al
    Respiratory distress syndrome in preterm infants of less than 32 weeks: What difference does giving 100 or 200 mg/kg of exogenous surfactant make?
    Pediatr Pulmonol. 2022 May 16. doi: 10.1002/ppul.25979.
    >> Share

  356. MONTERO-GATO J, Rodeno-Fernandez L, Serna-Guerediaga I, Aguirre-Unceta-Barrenechea A, et al
    Response to the letter entitled: "Ultrasound of pneumothorax in neonates: Diagnostic value of the anterior transverse plane and of mirrored ribs; Methodological issues".
    Pediatr Pulmonol. 2022 May 16. doi: 10.1002/ppul.25976.
    >> Share

  357. SABOUR S
    Ultrasound of pneumothorax in neonates: Diagnostic value of the anterior transverse plane and of mirrored ribs; Methodological issues.
    Pediatr Pulmonol. 2022 May 16. doi: 10.1002/ppul.25977.
    >> Share

  358. WELBEL RZ, Rand CM, Zhou A, Fadl-Alla A, et al
    Neurocognitive Monitoring in Congenital Central Hypoventilation Syndrome with the NIH Toolbox.
    Pediatr Pulmonol. 2022 May 16. doi: 10.1002/ppul.25973.
    >> Share

  359. LIM AM, Tan PL, Visruthan NK, Fong N, et al
    HIDEA Syndrome: A rare cause of congenital hypoventilation in a premature infant.
    Pediatr Pulmonol. 2022 May 11. doi: 10.1002/ppul.25966.
    >> Share

  360. GOUSSARD P, Merven M, Parker N, Gie A, et al
    Foreign body aspiration in two young infants: The devil in the carpet.
    Pediatr Pulmonol. 2022 May 11. doi: 10.1002/ppul.25965.
    >> Share

  361. ARIFF S, Ali KQ, Tessaro MO, Ansari U, et al
    Diagnostic Accuracy of Point-of-Care Ultrasound Compared to Standard-of-Care Methods for Endotracheal Tube Placement in Neonates.
    Pediatr Pulmonol. 2022 May 2. doi: 10.1002/ppul.25955.
    >> Share

  362. FRAUCHIGER BS, Oestreich MA, Wyler F, Monney N, et al
    Do clinimetric properties of LCI change after correction of signal processing?
    Pediatr Pulmonol. 2022;57:1180-1187.
    >> Share

  363. KENIS-COSKUN O, Aksoy AN, Kumas EN, Yilmaz A, et al
    The effect of telerehabilitation on quality of life, anxiety, and depression in children with cystic fibrosis and caregivers: A single-blind randomized trial.
    Pediatr Pulmonol. 2022;57:1262-1271.
    >> Share

  364. KRAMER-GOLINKOFF E, Camacho A, Kramer L, Taylor-Cousar JL, et al
    A survey: Understanding the health and perspectives of people with CF not benefiting from CFTR modulators.
    Pediatr Pulmonol. 2022;57:1253-1261.
    >> Share

  365. LIM JT, Ly NP, Willen SM, Iwanaga K, et al
    Food insecurity and mental health during the COVID-19 pandemic in cystic fibrosis households.
    Pediatr Pulmonol. 2022;57:1238-1244.
    >> Share

  366. ASFUROGLU P, Sismanlar Eyuboglu T, Aslan AT, Gursoy TR, et al
    The success of the Cystic Fibrosis Registry of Turkey for improvement of patient care.
    Pediatr Pulmonol. 2022;57:1245-1252.
    >> Share

    April 2022
  367. GHOSH RN, Guglani L, Westbrook AL, Mao CY, et al
    Impaired Ventilation during Six-Minute Walk Test in Congenital Central Hypoventilation Syndrome.
    Pediatr Pulmonol. 2022 Apr 22. doi: 10.1002/ppul.25940.
    >> Share

  368. IZQUIERDO ME, Marion CR, Moore WC, Raraigh K, et al
    DNA Sequencing Analysis of Cystic Fibrosis Transmembrane Regulator Gene Identifies Cystic Fibrosis-Associated Variants in the Severe Asthma Research Program.
    Pediatr Pulmonol. 2022 Apr 21. doi: 10.1002/ppul.25939.
    >> Share

  369. ZAITSU M, Matsuo M
    Transient low IgG4 levels cause recurrent wheezing requiring multiple hospitalizations in infancy.
    Pediatr Pulmonol. 2022 Apr 18. doi: 10.1002/ppul.25927.
    >> Share

  370. FELDMAN K, Nitkin CR, Cuna A, Oschman A, et al
    Corticosteroid Response Predicts Bronchopulmonary Dysplasia Status at 36 Weeks in Preterm Infants Treated with Dexamethasone: A Pilot Study.
    Pediatr Pulmonol. 2022 Apr 17. doi: 10.1002/ppul.25928.
    >> Share

  371. KOUCKY V, Komarek A, Pohunek P
    Repeatability of lung clearance index in infants with cystic fibrosis and recurrent wheeze.
    Pediatr Pulmonol. 2022 Apr 13. doi: 10.1002/ppul.25921.
    >> Share

  372. MATERA L, Nenna R, Frassanito A, Petrarca L, et al
    Low lymphocyte count: a clinical severity marker in infants with bronchiolitis.
    Pediatr Pulmonol. 2022 Apr 11. doi: 10.1002/ppul.25919.
    >> Share

  373. BISQUERA A, MBChB CH, Lunt A, Zivanovic S, et al
    Longitudinal changes in lung function in very prematurely born young people receiving high frequency oscillation or conventional ventilation from birth.
    Pediatr Pulmonol. 2022 Apr 6. doi: 10.1002/ppul.25918.
    >> Share

  374. CALISKAN AB, Horani A, Manion M, Brody SL, et al
    Variations in infection control practices suggest a need for guidelines in primary ciliary dyskinesia patient care.
    Pediatr Pulmonol. 2022;57:1072-1075.
    >> Share

  375. MANZAR S
    Successful Extubation in Preterm Infants.
    Pediatr Pulmonol. 2022 Apr 1. doi: 10.1002/ppul.25908.
    >> Share

  376. KENNEDY C, Greenberg I, Perez GF, Chaney H, et al
    Measuring the impact of an empiric antibiotic algorithm for pulmonary exacerbation in children and young adults with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:965-975.
    >> Share

  377. MANIKA K, Hatziagorou E, Kotoulas SC, Kyrvasili SS, et al
    Adherence to inhaled therapies over 4 years in people with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:956-964.
    >> Share

  378. LAI HJ, Chin LH, Murali S, Bach T, et al
    Vitamins A, D, E status as related to supplementation and lung disease markers in young children with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:935-944.
    >> Share

  379. IMBURGIA TA, Engdahl SR, Pettit RS
    Evaluation of the safety of cefepime prolonged infusions in pediatric patients with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:919-925.
    >> Share

  380. SHAKKOTTAI A, Irani S, Nasr SZ, O'Brien LM, et al
    Risk factors for obstructive sleep apnea in cystic fibrosis.
    Pediatr Pulmonol. 2022;57:926-934.
    >> Share

  381. SAKON C, Alicea LA, Patacca H, Brown CD, et al
    Opportunity for pharmacogenomic testing in patients with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:903-907.
    >> Share

  382. ZAMPOLI M, Kassanjee R, Verstraete J, Westwood A, et al
    Trends in cystic fibrosis survival over 40 years in South Africa: An observational cohort study.
    Pediatr Pulmonol. 2022;57:908-918.
    >> Share

    March 2022
  383. GUPTA VS, Wilson C, Popp EC, Zhaorigetu S, et al
    Neonatal rodent ventilation and clinical correlation in congenital diaphragmatic hernia.
    Pediatr Pulmonol. 2022 Mar 30. doi: 10.1002/ppul.25911.
    >> Share

  384. SCHOBER M, Bohnhorst B, Annon-Eberharter N, Wald M, et al
    Dead space washout by intentional leakage flow during conventional ventilation of premature infants - an experimental study.
    Pediatr Pulmonol. 2022 Mar 30. doi: 10.1002/ppul.25906.
    >> Share

  385. RALLIS D, Baltogianni M, Dermitzaki N, Balomenou F, et al
    Clara Cell Protein Expression Amongst Infants with Respiratory Distress Syndrome.
    Pediatr Pulmonol. 2022 Mar 18. doi: 10.1002/ppul.25897.
    >> Share

  386. ARAKI R, Tomotaki S, Akita M, Motokura K, et al
    Effect of doxapram on the electrical activity of the diaphragm waveform pattern of preterm infants.
    Pediatr Pulmonol. 2022 Mar 11. doi: 10.1002/ppul.25889.
    >> Share

  387. PIATEK K, Lehtonen L, Parikka V, Setanen S, et al
    Implementation of neurally adjusted ventilatory assist and high flow nasal cannula in very preterm infants in a tertiary level NICU.
    Pediatr Pulmonol. 2022 Mar 3. doi: 10.1002/ppul.25879.
    >> Share

  388. GOUSSARD P, Schubert P, Parker N, Myburgh C, et al
    GOUSSARD et al."To the Editor"Fatal SARS-CoV-2 Omicron variant in a young infant: Autopsy findings.
    Pediatr Pulmonol. 2022 Mar 3. doi: 10.1002/ppul.25881.
    >> Share

  389. SUNMAN B, Emiralioglu N, Hazirolan G, Ademhan Tural D, et al
    Impact of Achromobacter spp. isolation on clinical outcomes in children with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:658-666.
    >> Share

  390. WRIGHT BA, Ketchen NK, Rasmussen LN, Bartels AR, et al
    Impact of elexacaftor/tezacaftor/ivacaftor on vitamin D absorption in cystic fibrosis patients.
    Pediatr Pulmonol. 2022;57:655-657.
    >> Share

  391. SATHE M, Paul GR, Faro A
    A step back in time: The basics of CF care still matter!
    Pediatr Pulmonol. 2022;57:597-599.
    >> Share

  392. KAUR H, Pandey S, Jat KR, Lodha R, et al
    Predictors of mortality in children with cystic fibrosis in India.
    Pediatr Pulmonol. 2022;57:648-654.
    >> Share

    February 2022
  393. CORSINI I, Ciarcia M, Ficial B, Capasso L, et al
    LUNG ULTRASOUND SCORES IN NEONATAL CLINICAL PRACTICE: A NARRATIVE REVIEW OF THE LITERATURE.
    Pediatr Pulmonol. 2022 Feb 28. doi: 10.1002/ppul.25875.
    >> Share

  394. KORPPI M
    Eosinophil activity in infancy predicts the outcome of infant bronchiolitis.
    Pediatr Pulmonol. 2022 Feb 27. doi: 10.1002/ppul.25871.
    >> Share

  395. SCHNAPPER M, Dalal I, Mandelberg A, Sternfeld AR, et al
    Bronchoscopy in the management of children from developing countries undergoing congenital heart surgery.
    Pediatr Pulmonol. 2022 Feb 24. doi: 10.1002/ppul.25869.
    >> Share

  396. BUCK CO, Taylor SN
    Commentary on "Compatibility of rapid enteral feeding advances and noninvasive ventilation in preterm infants - an observational study".
    Pediatr Pulmonol. 2022 Feb 21. doi: 10.1002/ppul.25867.
    >> Share

  397. BEHNKE J, Estreich V, Oehmke F, Zimmer KP, et al
    Compatibility of rapid enteral feeding advances and non-invasive ventilation in preterm infants - an observational study.
    Pediatr Pulmonol. 2022 Feb 21. doi: 10.1002/ppul.25868.
    >> Share

  398. XU KK, Wegner DJ, Geurts LC, Heins HB, et al
    Biologic Characterization of ABCA3 Variants in Lung Tissue from Infants and Children with ABCA3 Deficiency.
    Pediatr Pulmonol. 2022 Feb 15. doi: 10.1002/ppul.25862.
    >> Share

  399. RAGAN H, Autry E, Bomersback T, Hewlett J, et al
    The use of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis postliver transplant: A case series.
    Pediatr Pulmonol. 2022;57:411-417.
    >> Share

  400. ANTOS NJ, Savant AP
    Cystic fibrosis year in review 2020: Section 2 pulmonary disease, infections, and inflammation.
    Pediatr Pulmonol. 2022;57:347-360.
    >> Share

  401. MCBENNETT KA, Davis PB, Konstan MW
    Increasing life expectancy in cystic fibrosis: Advances and challenges.
    Pediatr Pulmonol. 2022;57 Suppl 1:S5-S12.
    >> Share

  402. JOBANPUTRA A, Jagpal S, Marulanda P, Ramagopal M, et al
    An overview of noninvasive ventilation in cystic fibrosis.
    Pediatr Pulmonol. 2022;57 Suppl 1:S101-S112.
    >> Share

  403. GABEL ME, Fox CK, Grimes RA, Lowman JD, et al
    Overweight and cystic fibrosis: An unexpected challenge.
    Pediatr Pulmonol. 2022;57 Suppl 1:S40-S49.
    >> Share

  404. SALA MA, Vitale KM, Prickett M
    Looking toward the future: Approaching care of the aging CF patient.
    Pediatr Pulmonol. 2022;57 Suppl 1:S113-S117.
    >> Share

  405. ROWBOTHAM NJ, Daniels TE
    Airway clearance and exercise for people with cystic fibrosis: Balancing longevity with life.
    Pediatr Pulmonol. 2022;57 Suppl 1:S50-S59.
    >> Share

  406. WRIGHT M, Wright T
    Health disparity in CF: Perspectives from a lived experience.
    Pediatr Pulmonol. 2022;57 Suppl 1:S13-S16.
    >> Share

  407. WEST NE, Kazmerski TM, Taylor-Cousar JL, Tangpricha V, et al
    Optimizing sexual and reproductive health across the lifespan in people with cystic fibrosis.
    Pediatr Pulmonol. 2022;57 Suppl 1:S89-S100.
    >> Share

  408. LAHIRI T, Sullivan JS
    Recent advances in the early treatment of cystic fibrosis: Bridging the gap to highly effective modulator therapy.
    Pediatr Pulmonol. 2022;57 Suppl 1:S60-S74.
    >> Share

  409. KAZMERSKI TM, West NE, Jain R, Uluer A, et al
    Family-building and parenting considerations for people with cystic fibrosis.
    Pediatr Pulmonol. 2022;57 Suppl 1:S75-S88.
    >> Share

  410. GRANT JJ, McDade EJ, Zobell JT, Young DC, et al
    The indispensable role of pharmacy services and medication therapy management in cystic fibrosis.
    Pediatr Pulmonol. 2022;57 Suppl 1:S17-S39.
    >> Share

    January 2022
  411. SOLA-MARTINEZ RA, Sanchez-Solis M, Lozano-Terol G, Gallego-Jara J, et al
    Relationship between lung function and exhaled volatile organic compounds in healthy infants.
    Pediatr Pulmonol. 2022 Jan 29. doi: 10.1002/ppul.25849.
    >> Share

  412. BEQIRAJ-ZEQIRAJ Q, Thaci Q, Sahiti F, Kovac Z, et al
    Rho-kinase inhibitors protect against neonatal hyperoxia-induced airway hyperreactivity in a rat pup model: role of prostaglandin F2alpha.
    Pediatr Pulmonol. 2022 Jan 28. doi: 10.1002/ppul.25848.
    >> Share

  413. GEORGE A, Ortenberg R, Pinto S
    A case of Recurrent Pneumothoraces in a Newborn.
    Pediatr Pulmonol. 2022 Jan 25. doi: 10.1002/ppul.25844.
    >> Share

  414. IWAI M, Yoshimatsu H, Naramura T, Imamura H, et al
    Procalcitonin is associated with postnatal respiratory condition severity in preterm neonate: Conclusion: The serum PCT levels in preterm neonates were associated with postnatal respiratory condition severity.
    Pediatr Pulmonol. 2022 Jan 22. doi: 10.1002/ppul.25846.
    >> Share

  415. DE QUEIROZ ANDRADE E, Bayfield KJ, Blaxland A, Wong A, et al
    Exposure to 4% SF6 during multiple breath washout affects subsequent infant tidal breathing analysis.
    Pediatr Pulmonol. 2022 Jan 20. doi: 10.1002/ppul.25820.
    >> Share

  416. ELGENDY MM, Aly H, Adisa A, Mohamed MA, et al
    Disparities in tracheostomies and gastrostomy tubes in infants at the edge of viability.
    Pediatr Pulmonol. 2022 Jan 20. doi: 10.1002/ppul.25841.
    >> Share

  417. RUSCONI F, Lombardi E, Spada E, Brescianini S, et al
    Lung function at school age in infants with lower respiratory tract infections with and without wheezing: a birth cohort study.
    Pediatr Pulmonol. 2022 Jan 19. doi: 10.1002/ppul.25835.
    >> Share

  418. LI J, Zhang J, Hao Q, Chen H, et al
    Erythropoietin for preventing bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis.
    Pediatr Pulmonol. 2022 Jan 18. doi: 10.1002/ppul.25837.
    >> Share

  419. BEYDON N, Lucas JS
    Letter to the Editor on "Feasibility of nasal NO screening in healthy newborns".
    Pediatr Pulmonol. 2022 Jan 17. doi: 10.1002/ppul.25784.
    >> Share

  420. MOHSEN N, Nasef N, Elkhouli M, Ghanem M, et al
    Predictors of Successful Trial off Continuous Positive Airway Pressure and High Flow Nasal Cannula in Preterm Infants < 30 weeks| gestation: A Retrospective Study.
    Pediatr Pulmonol. 2022 Jan 15. doi: 10.1002/ppul.25827.
    >> Share

  421. SANDVIK RM, Gustafsson PM, Lindblad A, Buchvald F, et al
    Contemporary N2 and SF6 multiple breath washout in infants and toddlers with cystic fibrosis.
    Pediatr Pulmonol. 2022 Jan 13. doi: 10.1002/ppul.25830.
    >> Share

  422. GATO JM, Fernandez LR, Guerediaga IS, Unceta-Barrenechea AA, et al
    Ultrasound of Pneumothorax in Neonates: Diagnostic Value of the Anterior Transverse Plane and of Mirrored Ribs.
    Pediatr Pulmonol. 2022 Jan 13. doi: 10.1002/ppul.25829.
    >> Share

  423. ADAIKALAM SA, Higano NS, Hysinger EB, Bates AJ, et al
    Tracheostomy prediction model in neonatal bronchopulmonary dysplasia via lung and airway MRI.
    Pediatr Pulmonol. 2022 Jan 13. doi: 10.1002/ppul.25826.
    >> Share

  424. WONG CK, Harris L, Hicks M, Majaesic C, et al
    Tracheostomies in Term and Preterm Infants: A Single Center Canadian Retrospective Cohort.
    Pediatr Pulmonol. 2022 Jan 11. doi: 10.1002/ppul.25823.
    >> Share

  425. DANI C, Ciarcia M, Miselli F, Luzzati M, et al
    MEASUREMENT OF LUNG OXYGENATION BY NEAR INFRARED SPECTROSCOPY IN PRETERM INFANTS WITH RESPIRATORY DISTRESS SYNDROME: A PROOF OF CONCEPT STUDY.
    Pediatr Pulmonol. 2022 Jan 11. doi: 10.1002/ppul.25824.
    >> Share

  426. ROSENFELD N, Mandelberg A, Dalal I, Tasher D, et al
    The Impact of the COVID-19 Pandemic on respiratory morbidity during infancy: A birth-cohort study.
    Pediatr Pulmonol. 2022 Jan 11. doi: 10.1002/ppul.25822.
    >> Share

  427. O'CONNOR K, Hurst C, Llewellyn S, Davies M, et al
    Factors associated with successful extubation following the first course of systemic dexamethasone in ventilator dependent preterm infants with or at risk of developing bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2022 Jan 7. doi: 10.1002/ppul.25821.
    >> Share

  428. GENTLE SJ, Sant'Anna G, Carlo WA
    Using Dexamethasone Wisely in Invasively Ventilated Preterm Infants.
    Pediatr Pulmonol. 2022 Jan 7. doi: 10.1002/ppul.25819.
    >> Share

  429. GE H, Qiao Y, Ge J, Li J, et al
    Effects of early Vitamin D supplementation on the prevention of bronchopulmonary dysplasia in preterm infants.
    Pediatr Pulmonol. 2022 Jan 6. doi: 10.1002/ppul.25813.
    >> Share

  430. KIELT MJ, Murphy A, Smathers J, Bates M, et al
    In-hospital respiratory viral infections for patients with established BPD in the SARS-CoV-2 era.
    Pediatr Pulmonol. 2022;57:200-208.
    >> Share

  431. FETTES E, Riley M, Brotherston S, Doughty C, et al
    "You're on mute!" Does pediatric CF home spirometry require physiologist supervision?
    Pediatr Pulmonol. 2022;57:278-284.
    >> Share

  432. ADEMHAN TURAL D, Yalcin E, Emiralioglu N, Ozsezen B, et al
    Comparison of inhaled mannitol/dornase alfa combination and daily dornase alfa alone in children with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:142-151.
    >> Share

  433. POORE TS, Meier M, Towler E, Martiniano SL, et al
    Clinical characteristics of people with cystic fibrosis and frequent fungal infection.
    Pediatr Pulmonol. 2022;57:152-161.
    >> Share

  434. MARIANI A, Gambazza S, Carta F, Ambrogi F, et al
    Prevalence and factors associated with urinary incontinence in females with cystic fibrosis: An Italian single-center cross-sectional analysis.
    Pediatr Pulmonol. 2022;57:132-141.
    >> Share

  435. SEBLANI MD, McColley SA, Gong S, Bass LM, et al
    A rare case of pancytopenia in a child with cystic fibrosis: Can copper cure it all?
    Pediatr Pulmonol. 2022;57:317-319.
    >> Share

  436. DEVI U, Roberts KD, Pandita A
    A systematic review of surfactant delivery via laryngeal mask airway, pharyngeal instillation, and aerosolization: Methods, limitations, and outcomes.
    Pediatr Pulmonol. 2022;57:9-19.
    >> Share

    December 2021
  437. RIGOTTI C, Zannin E, Abdelfattah AS, Ventura ML, et al
    Assessment of bronchodilator response by forced oscillation technique in a preterm infant with evolving bronchopulmonary dysplasia: a case report.
    Pediatr Pulmonol. 2021 Dec 30. doi: 10.1002/ppul.25812.
    >> Share

  438. SZABO H, Baraldi E, Colin AA
    Corticosteroids in the prevention and treatment of infants with bronchopulmonary dysplasia: Part II. Inhaled corticosteroids alone or in combination with surfactants.
    Pediatr Pulmonol. 2021 Dec 29. doi: 10.1002/ppul.25808.
    >> Share

  439. SZABO H, Baraldi E, Colin AA
    Corticosteroids in the prevention and treatment of infants with bronchopulmonary dysplasia: Part I. Systemic corticosteroids.
    Pediatr Pulmonol. 2021 Dec 29. doi: 10.1002/ppul.25805.
    >> Share

  440. LANGFELDER-SCHWIND E, Raraigh KS, Parad RB
    Genetic counseling access for parents of newborns who screen positive for cystic fibrosis: consensus guidelines.
    Pediatr Pulmonol. 2021 Dec 29. doi: 10.1002/ppul.25806.
    >> Share

  441. GUPTA N, Chattopadhyay A, Nyayadhish RK, Saikia D, et al
    Necrotising MRSA pneumonia with mycotic pulmonary artery pseudo - aneurysm in an infant.
    Pediatr Pulmonol. 2021 Dec 22. doi: 10.1002/ppul.25800.
    >> Share

  442. PELES G, Paz-Levy D, Wainstock T, Goldbart A, et al
    Pediatric respiratory hospitalizations in small for gestational age neonates born at term.
    Pediatr Pulmonol. 2021 Dec 20. doi: 10.1002/ppul.25797.
    >> Share

  443. BALAZS G, Balajthy A, Riszter M, Kovacs T, et al
    Incidence, predictors of success and outcome of LISA in very preterm infants.
    Pediatr Pulmonol. 2021 Dec 20. doi: 10.1002/ppul.25798.
    >> Share

  444. FRASSANITO A, Nenna R, Arima S, Petrarca L, et al
    Modifiable environmental factors predispose term infants to bronchiolitis but bronchiolitis itself predisposes to respiratory sequelae.
    Pediatr Pulmonol. 2021 Dec 17. doi: 10.1002/ppul.25794.
    >> Share

  445. RAMIREZ-SUAREZ KI, Barrera CA, Otero HJ, Biko DM, et al
    Pilot study for comparative assessment of dual-energy computed tomography and single-photon emission computed tomography V/Q scanning for lung perfusion evaluation in infants.
    Pediatr Pulmonol. 2021 Dec 16. doi: 10.1002/ppul.25788.
    >> Share

  446. XU W, Gao Y, Li W, Chen Z, et al
    A National descriptive epidemiologic analysis on congenital pulmonary airway malformation in China, 2010-2019.
    Pediatr Pulmonol. 2021 Dec 9. doi: 10.1002/ppul.25785.
    >> Share

  447. VIRGIN FW, Thurm C, Sanders DB, Freeman AJ, et al
    Prevalence, variability, and predictors of sinus surgery in pediatric patients with cystic fibrosis.
    Pediatr Pulmonol. 2021;56:4029-4038.
    >> Share

  448. MASSIE J
    Miracles in my time: Reflections of a pediatric respiratory physician.
    Pediatr Pulmonol. 2021;56:3586-3591.
    >> Share

  449. ALIBAKHSHI R, Mohammadi A, Khamooshian S, Kazeminia M, et al
    CFTR gene mutation spectrum among 735 Iranian patients with cystic fibrosis: A comprehensive systematic review.
    Pediatr Pulmonol. 2021;56:3644-3656.
    >> Share

  450. ANDERSON A, McCoy L, Pettit RS, Wright BA, et al
    Early insurance coverage of elexacaftor/tezacaftor/ivacaftor for cystic fibrosis.
    Pediatr Pulmonol. 2021;56:4053-4054.
    >> Share

  451. WILSON LM, Ellis MJ, Lane RL, Wilson JW, et al
    Development of the A-STEP: A new incremental maximal exercise capacity step test in cystic fibrosis.
    Pediatr Pulmonol. 2021;56:3777-3784.
    >> Share

  452. BOKOV P, Gerardin M, Le Clainche L, Houdouin V, et al
    Impulse oscillometry indices to detect an abnormal lung clearance index in childhood cystic fibrosis.
    Pediatr Pulmonol. 2021;56:3752-3757.
    >> Share

  453. MURSALOGLU HH, Akin C, Yilmaz Yegit C, Ergenekon AP, et al
    Comparison of intravenous and non-intravenous antibiotic regimens in eradication of P. aeruginosa and MRSA in cystic fibrosis.
    Pediatr Pulmonol. 2021;56:3745-3751.
    >> Share

  454. MCCASHNEY A, Robinson P
    Structural lung disease following allergic bronchopulmonary aspergillosis complicating pediatric cystic fibrosis.
    Pediatr Pulmonol. 2021;56:3737-3744.
    >> Share

  455. GOETZ DM, Savant AP
    Review of CFTR modulators 2020.
    Pediatr Pulmonol. 2021;56:3595-3606.
    >> Share

  456. OCHS MA, Dillman NO, Caverly LJ, Chaffee VD, et al
    Aminoglycoside dosing and monitoring for Pseudomonas aeruginosa during acute pulmonary exacerbations in cystic fibrosis.
    Pediatr Pulmonol. 2021;56:3634-3643.
    >> Share

    November 2021
  457. NAYIR BUYUKSAHIN H, Emiralioglu N, Ozsezen B, Ademhan Tural D, et al
    Cystic Fibrosis Newborn Screening: Five-year Experience from a Tertiary Care Center.
    Pediatr Pulmonol. 2021 Nov 29. doi: 10.1002/ppul.25778.
    >> Share

  458. PELUSO AM, Othman HF, Karnati S, Sammour I, et al
    Epidemiologic evaluation of inhaled nitric oxide use among neonates with gestational age less than 35 weeks.
    Pediatr Pulmonol. 2021 Nov 29. doi: 10.1002/ppul.25775.
    >> Share

  459. WHITE H, Sobelman C, Kremer T, Lee A, et al
    Does Recorded Oximetry Utilizing a Consensus Based Algorithm Compare to Polysomnography in Discontinuing Home Oxygen Therapy in Premature Infants.
    Pediatr Pulmonol. 2021 Nov 23. doi: 10.1002/ppul.25770.
    >> Share

  460. BUENDIA JA, Ramirez C, Benjumea-Bedoya D
    Bronchopulmonary dysplasia: incidence and severity in premature infants born at high altitude.
    Pediatr Pulmonol. 2021 Nov 18. doi: 10.1002/ppul.25763.
    >> Share

  461. NOBILE S, Marchionni P, Meneghin F, Salvatore S, et al
    Esophageal impedance baseline in infants with bronchopulmonary dysplasia: a pilot study.
    Pediatr Pulmonol. 2021 Nov 15. doi: 10.1002/ppul.25758.
    >> Share

  462. TANG W, Chen S, Shi D, Ai T, et al
    Effectiveness and safety of early combined utilization of budesonide and surfactant by airway for Bronchopulmonary dysplasia prevention in premature infants with RDS: A meta-analysis.
    Pediatr Pulmonol. 2021 Nov 15. doi: 10.1002/ppul.25759.
    >> Share

  463. VOYNOW JA, Feng R, Ren CL, Dylag AM, et al
    Pulmonary function tests in extremely low gestational age infants at one year of age.
    Pediatr Pulmonol. 2021 Nov 14. doi: 10.1002/ppul.25757.
    >> Share

  464. CUEVAS GUAMAN M, Dahm PH, Welty SE
    The challenge of accurately describing the epidemiology of bronchopulmonary dysplasia (BPD) based on the various current definitions of BPD.
    Pediatr Pulmonol. 2021;56:3527-3532.
    >> Share

  465. HYSINGER EB
    Central airway issues in bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2021;56:3518-3526.
    >> Share

  466. YALLAPRAGADA SG, Savani RC, Goss KN
    Cardiovascular impact and sequelae of bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2021;56:3453-3463.
    >> Share

  467. COLLACO JM, McGrath-Morrow SA
    Bronchopulmonary dysplasia as a determinant of respiratory outcomes in adult life.
    Pediatr Pulmonol. 2021;56:3464-3471.
    >> Share

  468. BAKER CD
    Chronic respiratory failure in bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2021;56:3490-3498.
    >> Share

  469. ALLEN J, Panitch H
    Bronchopulmonary dysplasia-A historical perspective.
    Pediatr Pulmonol. 2021;56:3478-3489.
    >> Share

    October 2021
  470. BAKHLE A, Sreekumar K, Baracho B, Sardessai S, et al
    Cavitary lung lesions in a neonate: Potential manifestation of COVID-19 related multisystem inflammatory syndrome.
    Pediatr Pulmonol. 2021 Oct 29. doi: 10.1002/ppul.25732.
    >> Share

  471. LI J, Xu H
    Comparisons of two definitions of Bronchopulmonary Dysplasia for the premature infants.
    Pediatr Pulmonol. 2021 Oct 23. doi: 10.1002/ppul.25739.
    >> Share

  472. XU S, Yang C, Gan Y, Jiang G, et al
    A 4-day-old newborn with an isolated sternal cleft: A rare case and literature review.
    Pediatr Pulmonol. 2021 Oct 12. doi: 10.1002/ppul.25677.
    >> Share

  473. LEWIS L, Sinha I, Losty PD
    Respiratory Syncytial Virus Bronchiolitis in Congenital Diaphragmatic Hernia: A systematic review of prevalence rates and Palivizumab prophylaxis.
    Pediatr Pulmonol. 2021 Oct 6. doi: 10.1002/ppul.25717.
    >> Share

  474. DELL'ORTO V, Nobile S, Correani A, Marchionni P, et al
    Early nasal continuous positive airway pressure failure prediction in preterm infants less than 32 weeks gestational age suffering from respiratory distress syndrome.
    Pediatr Pulmonol. 2021 Oct 5. doi: 10.1002/ppul.25678.
    >> Share

  475. WANG Y, Hong X, Yao TC, Tsai HJ, et al
    Interaction of maternal asthma history and plasma folate levels on child asthma risk in the Boston Birth Cohort.
    Pediatr Pulmonol. 2021 Oct 4. doi: 10.1002/ppul.25680.
    >> Share

  476. ANDERSON E, Gregoski MJ, Gehle D, Head WT, et al
    Severity of respiratory disease is correlated with time of first oral feeding and need for a gastrostomy tube at discharge in premature infants born at <30 weeks of gestation.
    Pediatr Pulmonol. 2021 Oct 1. doi: 10.1002/ppul.25713.
    >> Share

  477. DEVI U, Pandita A
    Surfactant delivery via thin catheters: Methods, limitations, and outcomes.
    Pediatr Pulmonol. 2021;56:3126-3141.
    >> Share

  478. SALVATORE D, Carnovale V, Majo F, Padoan R, et al
    Disease characterization of people with cystic fibrosis and a minimal function mutation: Data from the Italian registry.
    Pediatr Pulmonol. 2021;56:3232-3241.
    >> Share

  479. SHARMA PB, Sathe M, Savant AP
    Year in Review 2020: Multisystemic impact of cystic fibrosis.
    Pediatr Pulmonol. 2021;56:3110-3119.
    >> Share

  480. SATHE M, Sharma PB, Savant AP
    Year in review 2020: Nutrition and gastrointestinal disease in cystic fibrosis.
    Pediatr Pulmonol. 2021;56:3120-3125.
    >> Share

  481. DACCO V, Rosazza C, Malfitano A, Sciarrabba CS, et al
    Cytokine storm syndrome in a young patient with cystic fibrosis.
    Pediatr Pulmonol. 2021;56:3435-3437.
    >> Share

  482. ARARAT E, Sonawalla A, Berlinski A, Tas E, et al
    Nutritional status between 5-10 years is associated with cystic fibrosis-related diabetes in adolescence.
    Pediatr Pulmonol. 2021;56:3217-3222.
    >> Share

  483. LANDMESSER KB, Autry EB, Gardner BM, Bosko KA, et al
    Comparison of the predictive value of area under the curve versus maximum serum concentration of intravenous tobramycin in cystic fibrosis patients treated for an acute pulmonary exacerbation.
    Pediatr Pulmonol. 2021;56:3209-3216.
    >> Share

  484. CAUDRI D, Turkovic L, Klerk NH, Rosenow T, et al
    A screening tool to identify risk for bronchiectasis progression in children with cystic fibrosis.
    Pediatr Pulmonol. 2021 Oct 1. doi: 10.1002/ppul.25712.
    >> Share

    September 2021
  485. OZDEMIR R, Gokce IK, Tekin S, Taslidere AC, et al
    The Protective Effects of Apocynin in Hyperoxic Lung Injury in Neonatal Rats.
    Pediatr Pulmonol. 2021 Sep 28. doi: 10.1002/ppul.25707.
    >> Share

  486. BUECHEL F, Usemann J, Aline A, Salfeld P, et al
    Feasibility of nasal NO screening in healthy newborns.
    Pediatr Pulmonol. 2021 Sep 27. doi: 10.1002/ppul.25702.
    >> Share

  487. HATZIAGOROU E, Toulia I, Avramidou V, Kampouras A, et al
    Change in CF care during COVID-19 pandemic: Single-center experience in a middle-income setting.
    Pediatr Pulmonol. 2021;56:3065-3067.
    >> Share

  488. NAYIR BUYUKSAHIN H, Emiralioglu N, Ademhan Tural D, Ozsezen B, et al
    Impact of COVID-19 on pediatric pulmonology healthcare practice.
    Pediatr Pulmonol. 2021;56:2811-2817.
    >> Share

  489. COLLACO N, Legg J, Day M, Culliford D, et al
    COVID-19: Impact, experiences, and support needs of children and young adults with cystic fibrosis and parents.
    Pediatr Pulmonol. 2021;56:2845-2853.
    >> Share

  490. MUIRHEAD CA, Palmrose W, Condren M, Rotolo SM, et al
    A clinician survey of use assessment, documentation, and education about cannabis in persons with cystic fibrosis.
    Pediatr Pulmonol. 2021;56:2879-2887.
    >> Share

  491. PORTERFIELD HS, Maakestad LJ, LaMarche MM, Thurman AL, et al
    MRSA strains with distinct accessory genes predominate at different ages in cystic fibrosis.
    Pediatr Pulmonol. 2021;56:2868-2878.
    >> Share

  492. BELCHER R, Zobell JT
    Optimization of antibiotics for cystic fibrosis pulmonary exacerbations due to highly resistant nonlactose fermenting Gram negative bacilli: Meropenem-vaborbactam and cefiderocol.
    Pediatr Pulmonol. 2021;56:3059-3061.
    >> Share

  493. BURRUS TE, Vogt H, Pettit RS
    Impact of a pharmacy technician and pharmacist on time to inhaled tobramycin therapy in a pediatric cystic fibrosis clinic.
    Pediatr Pulmonol. 2021;56:2861-2867.
    >> Share

  494. THORAT T, McGarry LJ, Bonafede MM, Limone BL, et al
    Healthcare resource utilization and costs among children with cystic fibrosis in the United States.
    Pediatr Pulmonol. 2021;56:2833-2844.
    >> Share

    August 2021
  495. MCGLYNN JR, Aoyama BC, Collaco JM, McGrath-Morrow SA, et al
    Family history of asthma influences outpatient respiratory outcomes in children with BPD.
    Pediatr Pulmonol. 2021 Aug 8. doi: 10.1002/ppul.25603.
    >> Share

  496. OTA C, Saito R, Tominaga J, Iwasawa S, et al
    Bilateral lung transplantation in a 9-year-old girl with bronchopulmonary dysplasia with pulmonary hypertension.
    Pediatr Pulmonol. 2021 Aug 5. doi: 10.1002/ppul.25597.
    >> Share

  497. YANG K, He S, Dong W
    Gut microbiota and bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2021;56:2460-2470.
    >> Share

  498. GOMES A, Patusco R, Chung M, Dreker MR, et al
    The associations between pediatric weight status and cystic fibrosis-related diabetes status and health-related quality of life among children and young adults with cystic fibrosis: A systematic review.
    Pediatr Pulmonol. 2021;56:2413-2425.
    >> Share

    July 2021
  499. MALLOY KW, Austin ED
    Pulmonary Hypertension in the child with Bronchopulmonary Dysplasia.
    Pediatr Pulmonol. 2021 Jul 29. doi: 10.1002/ppul.25602.
    >> Share

  500. EPPS QJ, Epps KL, Young DC, Zobell JT, et al
    State of the art in cystic fibrosis pharmacology optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: III. Executive summary.
    Pediatr Pulmonol. 2021;56:1825-1837.
    >> Share

  501. GIFFORD AH, Sanville JL, Sathe M, Heltshe SL, et al
    Use of proton pump inhibitors is associated with lower hemoglobin levels in people with cystic fibrosis.
    Pediatr Pulmonol. 2021;56:2048-2056.
    >> Share

  502. POLLAK M, Shaw M, Wilson D, Solomon M, et al
    Bronchodilator responsiveness in cystic fibrosis children treated for pulmonary exacerbations.
    Pediatr Pulmonol. 2021;56:2036-2042.
    >> Share

  503. TREGGIARI D, Tridello G, Menin L, Borruso A, et al
    Role of sweat ion ratios in diagnosing cystic fibrosis.
    Pediatr Pulmonol. 2021;56:2023-2028.
    >> Share

  504. COLLINS R, Singh B, Payne DN, Bharat C, et al
    Effect of transfer from a pediatric to adult cystic fibrosis center on clinical status and hospital attendance.
    Pediatr Pulmonol. 2021;56:2029-2035.
    >> Share

  505. BOURGEOIS G, Magne F, Nove Josserand R, Durupt S, et al
    A formalized transition program for cystic fibrosis: A 10-year retrospective analysis of 97 patients in Lyon.
    Pediatr Pulmonol. 2021;56:2000-2006.
    >> Share

  506. ATLAS G, Yap M, Lim A, Vidmar S, et al
    The clinical features that contribute to poor bone health in young Australians living with cystic fibrosis: A recommendation for BMD screening.
    Pediatr Pulmonol. 2021;56:2014-2022.
    >> Share

  507. COHEN-CYMBERKNOH M, Ben Meir E, Gartner S, Reiter J, et al
    How abnormal is the normal? Clinical characteristics of CF patients with normal FEV1.
    Pediatr Pulmonol. 2021;56:2007-2013.
    >> Share

  508. HENTE E, Weiland J, Mullen L, Hawke J, et al
    Assessment of treatment burden and complexity in cystic fibrosis: A quality improvement project.
    Pediatr Pulmonol. 2021;56:1992-1999.
    >> Share

    June 2021
  509. BRUNO G, Donnarumma B, Inverardi A, Buonpensiero P, et al
    Long-term benefits of nusinersen in a child affected by cystic fibrosis and spinal muscular atrophy type 1.
    Pediatr Pulmonol. 2021;56:1806-1808.
    >> Share

  510. BUSTAMANTE AE, Fernandez LT, Rivas LC, Mercado-Longoria R, et al
    Disparities in cystic fibrosis survival in Mexico: Impact of socioeconomic status.
    Pediatr Pulmonol. 2021;56:1566-1572.
    >> Share

  511. PLESKOVA J, Koucky V, Medunova K, Vlckova B, et al
    Reflex zone stimulation reduces ventilation inhomogeneity in cystic fibrosis: A randomised controlled cross-over study.
    Pediatr Pulmonol. 2021;56:1558-1565.
    >> Share

  512. LEITE LR, Queiroz KCV, da Silva FH, Coelho CC, et al
    Clinical use of the modified shuttle test in children with cystic fibrosis: Is one test sufficient?
    Pediatr Pulmonol. 2021;56:1550-1557.
    >> Share

  513. HERNANDEZ AM, Burdick B, Adeyemi-Fowode O
    Reproductive health counseling and contraceptive use in adolescents with cystic fibrosis.
    Pediatr Pulmonol. 2021;56:1543-1549.
    >> Share

  514. YILMAZ YEGIT C, Ergenekon AP, Mursaloglu HH, Cenk M, et al
    The effects of nebulizer hygiene training on the practices of cystic fibrosis patients and caregivers.
    Pediatr Pulmonol. 2021;56:1527-1533.
    >> Share

  515. EPPS QJ, Epps KL, Zobell JT
    Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. Cephalosporins and penicillins latest update.
    Pediatr Pulmonol. 2021;56:1784-1788.
    >> Share

  516. MURSALOGLU HH, Yilmaz Yegit C, Ergenekon AP, Gokdemir Y, et al
    Screening of depression and anxiety in adolescents with cystic fibrosis and caregivers in Turkey by PHQ-9 and GAD-7 questionnaires.
    Pediatr Pulmonol. 2021;56:1514-1520.
    >> Share

  517. ASLANHAN U, Cakir E, Pur Ozyigit L, Kucuksezer UC, et al
    Pseudomonas aeruginosa colonization in cystic fibrosis: Impact on neutrophil functions and cytokine secretion capacity.
    Pediatr Pulmonol. 2021;56:1504-1513.
    >> Share

  518. LAFONT M, Morin C, Arrouy A, Rabeau A, et al
    Pediatrician intervention impacts parental smoking in cystic fibrosis, diabetes, and bronchiolitis.
    Pediatr Pulmonol. 2021;56:1716-1723.
    >> Share

  519. MCGARRY ME, McColley SA
    Cystic fibrosis patients of minority race and ethnicity less likely eligible for CFTR modulators based on CFTR genotype.
    Pediatr Pulmonol. 2021;56:1496-1503.
    >> Share

  520. ZOBELL JT, Moss J, Heuser S, Roe L, et al
    Understanding the expanding role of pharmacy services in outpatient cystic fibrosis care.
    Pediatr Pulmonol. 2021;56:1378-1385.
    >> Share

    May 2021
  521. PATEL M, McCracken C, Daley T, Stecenko A, et al
    Trajectories of oral glucose tolerance testing in cystic fibrosis.
    Pediatr Pulmonol. 2021;56:901-909.
    >> Share

  522. PERKINS RC, Shah M, Sawicki GS
    An evaluation of healthcare utilization and clinical charges in children and adults with cystic fibrosis.
    Pediatr Pulmonol. 2021;56:928-938.
    >> Share

  523. KONSTAN MW, Pasta DJ, VanDevanter DR, Wagener JS, et al
    Epidemiologic Study of Cystic Fibrosis: 25 years of observational research.
    Pediatr Pulmonol. 2021;56:823-836.
    >> Share

  524. EMIRZA C, Aslan GK, Kilinc AA, Cokugras H, et al
    Effect of expiratory muscle training on peak cough flow in children and adolescents with cystic fibrosis: A randomized controlled trial.
    Pediatr Pulmonol. 2021;56:939-947.
    >> Share

  525. EKINCI IB, Hizal M, Emiralioglu N, Ozcelik U, et al
    Differentially expressed genes associated with disease severity in siblings with cystic fibrosis.
    Pediatr Pulmonol. 2021;56:910-920.
    >> Share

  526. WILLIAMS WA 2ND, Jain M, Laguna TA, McColley SA, et al
    Preferences for disclosing adverse childhood experiences for children and adults with cystic fibrosis.
    Pediatr Pulmonol. 2021;56:921-927.
    >> Share

  527. PEREZ-TARAZONA S, Rueda Esteban S, Garcia-Garcia ML, Arroyas Sanchez M, et al
    Respiratory outcomes of "new" bronchopulmonary dysplasia in adolescents: A multicenter study.
    Pediatr Pulmonol. 2021;56:1205-1214.
    >> Share

  528. MUIRHEAD CA, Lanocha N, Markwardt S, MacDonald KD, et al
    Evaluation of rescue oral glucocorticoid therapy during inpatient cystic fibrosis exacerbations.
    Pediatr Pulmonol. 2021;56:891-900.
    >> Share

  529. OATES G, Rutland S, Juarez L, Friedman A, et al
    The association of area deprivation and state child health with respiratory outcomes of pediatric patients with cystic fibrosis in the United States.
    Pediatr Pulmonol. 2021;56:883-890.
    >> Share

  530. BEDI PK, DeHaan K, MacLean JE, Castro-Codesal ML, et al
    Predictors of longitudinal outcomes for children using long-term noninvasive ventilation.
    Pediatr Pulmonol. 2021;56:1173-1181.
    >> Share

    January 2021
  531. DU BERRY C, Westrupp N, Shanthikumar S, Welsh L, et al
    Associations between peak oxygen uptake, lung function and bronchiectasis in children with cystic fibrosis in the era of CFTR modulators.
    Pediatr Pulmonol. 2021 Jan 17. doi: 10.1002/ppul.25275.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016